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Abstract
Title: Parent Reported Executive Functioning Does Not Predict Memory Dysfunction in
Pediatric Epilepsy and Attention-Deficit/Hyperactivity Disorder
Author: Nicole J. Norheim, M.A., M.S.
Committee Chair: Frank Webbe, Ph.D.
Objective: Epilepsy and Attention-Deficit/Hyperactivity Disorder (ADHD) children are
vulnerable to executive functioning and memory difficulties. The interaction between EF and
memory is important to consider as EF impairments may put children at risk for experiencing
memory difficulties which can impact their academic performance and quality of life. However,
the evidence for the impact of EF on memory is very limited with only two studies to date
focusing on this association (Rzezak et al., 2012; Sepeta et al., 2017). This was the first study to
research the impact of executive dysfunction on memory in the pediatric epilepsy and ADHD
population.
Method: All participants (n=104) underwent a comprehensive neuropsychological evaluation to
assess current level of cognitive functioning. The total sample was further subdivided into four
diagnostic groups: intractable epilepsy group, controlled epilepsy group, comorbid
epilepsy/ADHD group, and ADHD group. The Behavior Rating Inventory of Executive Function
(BRIEF) was used to examine parent-reported executive functioning, while the California Verbal
Learning Test – Children’s (CVLT-C) and Children’s Memory Scale (CMS: Stories, Dots, and
Faces subtests) were used to measure memory.
Results: FSIQ, BRIEF GEC, and age of seizure onset provided a statistically significant
prediction of every delayed memory score for the epilepsy group [(CMS Stories Delay (F(3, 67)
iii

= 5.972, p = .001), (CVLT-C LDFR (F(3, 67) = 5.593, p = .002), (CMS Faces Delay (F(3, 66) =
3.918, p = .012), (CMS Dots Delay (F(3, 67) = 3.391, p = .023)]. Similarly, FSIQ and BRIEF
GEC provided a statistically significant prediction for a majority of the memory scales [(CMS
Dots Delay (F(2, 27) = 5.824, p = .008), (CVLT-C LDFR (F(2, 27) = 5.318, p = .011), (CMS
Stories Delay (F(2, 27) = 4.055, p = .029)]. However, FSIQ was the only unique predictor for
both the epilepsy and ADHD groups. Regarding memory, the epilepsy group demonstrated
average recognition, learning efficiency, learning slope, total word recall, and immediate and
delay recall scores. The ADHD group also demonstrated average immediate and delay recall
scores, initial attention, as well as no interference effects. There were significant diagnostic
group differences such that the epilepsy group exhibited significantly lower scores on CMS
Faces Delay (U = 666, p = .002) compared to the ADHD group. Additionally, the intractable
epilepsy group had significantly lower CMS Story Delay memory scores compared to that of the
controlled epilepsy and ADHD groups (F(3, 100) = 4.14, p = .008), as well as significantly lower
CMS Dot Delay memory scores compared to that of the ADHD group (F(3, 100) = 2.90, p =
.039).
Conclusions: Overall, this study found that intellectual functioning, executive functioning, and
age of seizure onset were significant predictors for every delayed memory score in children with
epilepsy. Similarly, intellectual and executive functioning were significant predictors for the
majority of the delayed memory scores in children with ADHD. However, intellectual
functioning was the only unique predictor in both models. Regarding memory, the overall
epilepsy group produced significantly lower scores on contextual visual memory whereas the
intractable epilepsy group obtained significantly lower scores on visual-spatial memory
iv

compared to that of the children with ADHD. Additionally, the intractable epilepsy group
demonstrated significantly lower verbal story memory than the ADHD and the controlled
epilepsy groups. Despite obtaining significantly lower memory scores than the children with
ADHD, the epilepsy groups still achieved average memory scores as well as an average learning
slope and total word recall. These findings are inconsistent with previous research which has
demonstrated children with epilepsy have significant memory difficulties. However, research in
this area has been inconsistent where some studies were unable to demonstrate a relationship
between epilepsy and memory difficulties. Our limited sample and small number of children
with temporal lobe epilepsy likely contributed to these inconsistent findings and lack of memory
weaknesses. It is difficult to determine whether the memory problems that children with epilepsy
demonstrate are unique and go beyond their intellectual weaknesses. Therefore, intellectual
functioning appears to have a predictive effect on children’s memory and is important to control
in future studies.
Keywords: executive functioning, memory, epilepsy, ADHD, children
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Parent Reported Executive Functioning Does Not Predict Memory Dysfunction in Pediatric
Epilepsy and Attention-Deficit/Hyperactivity Disorder
Introduction
Epilepsy is one of the most common neurological conditions around the world.
Approximately 50 million individuals worldwide suffer from epilepsy, with at least half of the
cases beginning in childhood or adolescence (WHO, 2017). In 2015, the Centers for Disease
Control and Prevention estimated that 5.1 million people in the United States have active
epilepsy, with about 470,000 being children (Zack & Kobau, 2015).
Once the seizure type has been established, monotherapy (single-drug therapy) should be
initiated by prescribing an anti-epileptic drug (AED). AED therapy is the initial treatment for
epilepsy; however, approximately 20% to 40% of epileptic individuals are AED therapy resistant
(French, 2007). Medically intractable epilepsy is characterized as persistent seizures despite
trials of three or more AED’s used in combination or alone. AED’s reduce seizures by
decreasing neuronal synchronization; however, this same action may affect normal neuronal
firing (Meador, 2006). Therefore, abnormal neuron firing can lead to neurodevelopmental
defects such as lower intelligence, language and memory difficulties, and attentiondeficit/hyperactivity disorder (ADHD) (Kellogg & Meador, 2017).
Although the majority of children with epilepsy may have average intellectual
functioning, other cognitive deficits may be present. In a study done by Høie and colleagues
(2008), approximately 35% of the children with epilepsy had severe non-verbal cognitive
problems and 31% demonstrated executive functioning difficulties. These cognitive deficits were
much more common in children with epilepsy when compared to the normative controls.
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Cognitive impairment among children with epilepsy can be due to a variety of variables
including the underlying epilepsy etiology, age of seizure onset, seizure frequency, epilepsy
syndrome, epilepsy duration, AED treatment or ADHD. ADHD is one of the most common
comorbid disorders among children diagnosed with epilepsy. ADHD prevalence estimates range
from 12% to 49% in epileptic children as compared to 5% among the general population.
Children with comorbid epilepsy and ADHD are at higher risk for elevated levels of cognitive
deficits than children with epilepsy alone.
One cognitive domain that appears to be impacted in children with epilepsy and/or
ADHD is memory. Children with epilepsy frequently demonstrate memory impairment and it is
one of the most common complaints of individuals diagnosed with epilepsy. A recent review
article by Menlove and Reilly (2015) found that the majority of studies (78%) report lower
memory performance for children with epilepsy when compared to controls and normative
scores. Predictors of memory impairment include a greater number of AED’s used and increased
seizure frequency (Menlove & Reilly, 2015). Additionally, the earlier age of seizure onset
(Lopes et al., 2014; Fuentes & Smith, 2015) and longer duration of epilepsy (Lopes et al., 2014;
Nolan et al., 2004) are related to poor memory performance. Furthermore, attention and
concentration can significantly affect memory. As a result, memory difficulties can be related to
poor selective attention, distractibility, as well as organization of information at encoding all of
which are the criteria for ADHD (Davidson, Troyer, & Mascovitch, 2006; Lezak, Howieson,
Bigler, & Tranel, 2012; Mahone & Schneider, 2012).
Executive functioning (EF) is another cognitive domain which appears to be impacted in
children with epilepsy and/or ADHD. EF is a domain of cognitive functioning which
encompasses inhibition, shifting, emotional control, initiation, working memory, planning,
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organization, and self-monitoring. The use of EF parental rating scales, as compared to
performance-based assessments, is limited among the pediatric epilepsy population. Performance
based measures may not always be sensitive to executive dysfunction due to the limited need for
self-initiated organization and problem solving when placed in a structured and quiet individual
testing environment. Among the few studies which used parental ratings, there appears to be
significantly more executive function problems elevated on the rating forms among the epileptic
children (Love et al., 2016; MacAllister et al., 2012a; Parrish et al., 2007; Sherman, Daniel, &
Eyrl, 2006; Slick, Lautzenhiser, Sherman, & Eyrl, 2006) as well as ADHD children (Toplak,
Bucciarelli, Jain, & Tannock, 2008a).
Furthermore, executive dysfunction can impact the memory of children with epilepsy and
ADHD. Therefore, the relationship between EF and memory in these populations is of interest.
Only two studies have been conducted which examine this relationship in pediatric epilepsy
patients (Rzezak et al., 2012; Sepeta et al., 2017). These two initial studies support the role of
executive functioning in memory retrieval, suggesting that executive dysfunction negatively
impacts memory in children with epilepsy. However, these studies did not include the possible
contributions of other conditions, such as the highly comorbid ADHD diagnosis in childhood
epilepsy, given the close relationship between memory and attention. Therefore, the purpose of
the present study is to investigate the effects of executive dysfunction on memory in pediatric
epilepsy and ADHD population. Evaluation of the relationship between EF as measured by the
Behavior Rating Inventory of Executive Function (BRIEF) and memory as measured by the
California Verbal Learning Test-Children (CVLT-C) and Children’s Memory Scale (CMS) in
children with epilepsy and/or ADHD will be conducted. Additionally, this study will investigate
the relationship of epilepsy variables (e.g., age of onset, AED’s, seizure frequency, epilepsy
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type) with the EF and memory variables of the children with epilepsy, as these variables have
been found to have an impact on both EF and memory domains. The clinical purpose of this
study has implications on how to identify the common executive dysfunctions and differences in
these populations. The interaction between EF and memory is important to consider as EF
impairments may put children at risk for experiencing memory difficulties which can impact
academic performance and quality of life.
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Review of Literature
Epilepsy
Epilepsy is the most common neurological conditions in the United States and around the
world. Approximately 50 million individuals worldwide suffer from epilepsy, with at least half
of the cases beginning in childhood or adolescence (WHO, 2017). In 2015, the Centers for
Disease Control and Prevention estimated that 5.1 million people in the United States have active
epilepsy, with about 470,000 being children (Zack & Kobau, 2015). The risk of epilepsy from
birth through 20 years is approximately 1% and reaches 3% at the age of 75 (Browne & Homes,
2008). The National Survey of Children’s Health Prevalence reported the current prevalence of
pediatric epilepsy was estimated to be 6.3 per 1,000 (Zack & Kobau, 2015). It is estimated 2.4
million individuals worldwide are diagnosed with epilepsy each year, with the majority among
children, particularly in their first year of life (WHO, 2017).
Clinical Definition. In 2005, the International League Against Epilepsy (ILAE) defined
epilepsy as a brain disorder characterized by reoccurring seizures with accompanying cognition,
neurobiological, psychological, and social difficulties (Fisher et al., 2014). However, for clinical
diagnostic purposes, the definition of epilepsy was translated into a practical definition in 2013.
The ILAE’s practical definition is described as a brain disease defined by one of the following:
1) At least two unprovoked seizures occurring at least 24 hours apart; 2) Over the course of 10
years, the occurrence of one unprovoked seizure with a probability of further seizures similar to
the general recurrence risk (at least 60%) after two unprovoked seizures; 3) Diagnosis of an
epilepsy syndrome (Fisher et al., 2014). Additionally, once an individual is past the relevant age
for an age-dependent epilepsy syndrome, the removal of the individual’s epilepsy diagnosis is
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warranted. Epilepsy is also described as being resolved for individuals who have not experienced
a seizure for 10 years, without the use of anti-epileptic drugs in the past five years.
Seizure Definition and Stages. Seizures are a result of uncontrollable, excessive, and
disorderly discharging of neurons which can be detected by clinical manifestations and/or
electroencephalographic (EEG) recordings (Browne & Homes, 2008). The University of Chicago
Medicine (2017) identified four stages of a seizure: 1) The aura stage is defined as the earliest
portion of a seizure recognized which can alert a person that a seizure may occur. The aura
symptoms (e.g., unpleasant smell, confusion, nausea, distorted emotion) depend on the affected
brain area; 2) The ictal (ictus) stage is described as the period in which the seizure is actually
occurring; 3) The postictal stage is the time immediately following a seizure where the body
begins to relax; 4) The interictal stage is defined as the interval between seizures. Each
individual can experience the stages of seizures differently, depending on the type, location,
severity, and duration of the seizure.
Seizure Classification and Types. Due to scientific advances, which have increased the
understanding of the epilepsies and their underlying mechanisms, the epileptic seizure and
syndrome classifications were updated in 2017 by the International League Against Epilepsy
(ILAE). The new classification presents three systematic diagnostic levels. First, the seizure type
is identified by the new 2017 ILAE Seizure Classification (i.e., focal, generalized, or unknown
onset). Once the seizure type has been identified, the epilepsy type diagnosis (i.e., focal,
generalized, combined generalized and focal, or unknown epilepsy) is established. Finally, there
may be a diagnosis of an epilepsy syndrome (Scheffer et al., 2017).
Initially in 1981, the ILAE classified seizures into either partial or of generalized onset.
Then in 1989, the ILAE incorporated the classification of specific epilepsy disorders. These
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classifications are still used today; however, there has been numerous revisions in terminology
and classifications since the 1980s (see Table 1) (Berg & Millichap, 2013; Fisher et al., 2017).
The most recent 2017 revision did not include an essential change in terminology or
classification; however, the revision allows greater flexibility when diagnosing seizure types
(Fisher et al., 2017).
Table 1
Changes in Seizure Type Classification from 1981 to 2017
1. “Partial” seizures are termed “focal” seizures.
2. Seizure types are classified as focal, generalized, or unknown onset.
3. Unknown onset seizures may have features that can still be classified*.
4. Awareness is a classifier of focal seizures.
Terminology such as simple partial, complex partial, dyscognitive*, psychic*, and
5.
secondarily generalized were eliminated.
6. New focal seizure types were included such as automatisms, autonomic, behavior arrest,
cognitive, emotional, hyperkinetic, sensory, and focal to bilateral tonic–clonic seizures.*
Additionally, focal or generalized seizures can be atonic, clonic, epileptic spasms,
myoclonic, and tonic seizures.*
7. New generalized seizure types included absence with eyelid myoclonia, myoclonic
absence, myoclonic–tonic–clonic*, myoclonic– atonic, and epileptic spasms*.
Note. * Differences from 2010 to 2017 ILAE revision (table adapted from Fisher et al., 2017).
Seizure classification begins with the determination of whether the initial seizure is focal,
generalized, or unknown onset. Focal seizures originate within networks localized in one
hemisphere, whereas generalized seizures involve bilaterally dispersed networks (Berg et al.,
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2010). However, the seizure onset may be unidentifiable or even obscured; therefore, the seizure
is described as of unknown onset (Fisher et al., 2017). Regarding focal seizures, the level of
awareness may be included in the seizure type. Focal seizure classification includes aware
seizures, impaired awareness seizures, and focal to bilateral tonic–clonic. Additionally, focal
aware or impaired awareness seizures may be further classified by categorizing the first
prominent symptom in the seizure, whether it be motor onset or nonmotor onset symptoms.
Motor symptoms at onset can include: automatisms, atonic, clonic, epileptic spasms,
hyperkinetic, myoclonic, or tonic. Nonmotor symptoms at onset can include: autonomic,
behavior arrest, cognitive, emotional, or sensory. The remaining focal seizure type, focal to
bilateral tonic–clonic, reflects a seizure which starts in one localized network of the brain, then
spreads bilaterally to the other hemisphere of the brain (Fisher et al., 2017).
Generalized seizures are similarly divided into motor and nonmotor (absence) seizures.
Motor symptoms at onset can include: tonic-clonic, clonic, tonic, myoclonic, myoclonic-tonicclonic, myoclonic-atonic, or epileptic spasms. Nonmotor symptoms at onset can include: typical,
atypical, myoclonic, or eyelid myoclonia (Fisher et al., 2017). Finally, the revised 2017
classification included qualifiers to the unknown onset seizure classification. These types of
seizures may be referred as “unclassified” or with motor or nonmotor onset features which
include: tonic–clonic, epileptic spasms, and behavior arrest (see Figure 1 for classification of
seizure types; figure adapted from Fisher et al., 2017).
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Figure 1
ILAE 2017 Classification of Seizure Types

Focal Onset

Aware

Generalized Onset

Impaired Awareness

Motor Onset

Nonmotor Onset

Tonic-clonic

Typical

Motor Onset

Nonmotor Onset

Clonic

Atypical

Automatisms
Atonic
Clonic
Epileptic Spasms
Hyperkinetic
Myoclonic
Tonic

Autonomic
Behavior Arrest
Cognitive
Emotional
Sensory

Tonic
Myoclonic
Myoclonic-tonic-clonic
Myoclonic-atonic
Atonic
Epileptic Spasms

Myoclonic
Eyelid Myoclonia

Focal to bilateral tonic-clonic

Unknown Onset
Motor Onset
Tonic-clonic
Epileptic Spasms

Nonmotor Onset
Behavior Arrest

Unclassified
Note. Figure adapted from Fisher et al., 2017.
Pediatric Epilepsy
Etiology of Pediatric Epilepsy. The etiology in pediatric epilepsy is rather diverse and
there is no single underlying pathology. In a study of epilepsy with an onset prior to 16 years of
age, approximately 82% of new cases were of unknown etiology (i.e., idiopathic etiology) (Berg,
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Shinnar, Levy, & Testa, 1999). The remaining 18% were classified as having symptomatic
etiology as there was an underlying cause such as cortical development malformations,
hydrocephalus, hypoxia, perinatal stroke, or genetic conditions. One of the most frequent causes
of pediatric epilepsy is malformation of cortical development (MCD) which vary in presentation
due to the diverse origin. In children, the most common MCD is focal cortical dysplasia (FCD)
(Santosh & Tasha, 2008). FCD consists of malformations in cortical lamination, neuronal
differentiation, or neuronal maturation (Gaitanis & Donahue, 2013). Consequences of FCD
include cognitive impairment, neurological deficits, and epilepsy. Hemimegalencephaly (HME)
is another a cortical malformation which is described as an overgrowth of the cerebral
hemisphere (Mirzaa & Podui, 2014). Not only is HME the most severe cortical malformation due
to the substantial structural abnormality, but most children will experience early onset intractable
epilepsy. Consequently, developmental delays occur early and are typically severe in children
diagnosed with HME. Other cortical malformation conditions include Rasmussen’s encephalitis,
tuberous sclerosis, Sturge-Weber syndrome, vascular malformations, ischemic lesions, and
epilepsy-associated tumors.
Treatments for Pediatric Epilepsy. The first step in managing an individual with
seizures is to conclude whether or not the patient actually has epilepsy (Browne & Homes,
2008). The diagnosis can be determined by a combination of history taking, behavioral
observation, neuroimaging, electroencephalography (EEG), and neuropsychological testing.
Once the seizure type has been established, monotherapy (single-drug therapy) should be
initiated by prescribing an anti-epileptic drug (e.g., Diazepam, Carbamazepine, Oxcarbazepine,
Phenytoin). However, if the first anti-epileptic drug (AED) reaches its maximal dosage and the
seizures continue to persist, a second AED should be added (polytherapy). AED therapy is the
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initial treatment for epilepsy; however, approximately 20% to 40% of epileptic individuals are
AED therapy resistant (French, 2007). Medically intractable epilepsy is characterized as failure
to achieve seizure freedom despite trials of two tolerated and appropriately chosen AEDs (Kwan
et al., 2010).
Anti-Epileptic Drugs. Antiepileptic drugs (AED’s) are used to control seizures and
reduce epileptic side effects. AED therapy typically controls seizures in 60% to 90% of patients;
therefore, it is the preferred initial treatment for epilepsy (Browne & Homes, 2008). AED’s
reduce seizure activity by acting on a variety of target molecules such as neurotransmitter
transporters, ion channels, and neurotransmitter enzymes to reduce the coordinated firing of
neurons in localized brain areas (Rogawski & Loscher, 2004). Despite being the preferred
epilepsy treatment, prolonged AED use may alter normal progress of cell proliferation,
neurogenesis, migration, programmed cell death, synaptogenesis, synaptic plasticity, and
myelination in the developing brain (Browne & Homes, 2008; Ikonomidou & Turski, 2009).
AED’s reduce seizures by decreasing neuronal synchronization; however, this same action may
affect normal neuronal firing (Meador, 2006). Therefore, abnormal neuron firing can lead to
neurodevelopmental defects such as lower intelligence, language and memory difficulties, and
attention-deficit/hyperactivity disorder (ADHD; Kellogg & Meador, 2017).
Cognitive Functioning in Pediatric Epilepsy. There is a high incidence of global and
specific cognitive deficits in children diagnosed with epilepsy. In a study done by Høie and
colleagues (2008), it was found that approximately 35% of the children with epilepsy had severe
non-verbal cognitive problems. In the remaining 65% of children with epilepsy, 45%
experienced psychosocial problems, 31% demonstrated executive functioning difficulties, and
26% exhibited mild cognitive problems. These cognitive deficits were much more common in
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children with epilepsy when compared to the normative controls. There are multiple factors
which can contribute to lower cognitive functioning such as the underlying epilepsy etiology, age
of seizure onset, seizure frequency, epilepsy syndrome, epilepsy duration, attentiondeficit/hyperactivity disorder (ADHD), and AED treatment (Berg et al., 2008a; Rantanen,
Ericksson, & Nieminen, 2011; Reilley et al., 2015; Shomakhova, Lebedeva, Ershov, Khomutov,
& Gudkova, 2012). The risk for falling below average cognition for chronological age increases
with each factor; therefore, there will be more pronounced cognitive effects when there are
multiple contributing factors (Berg et al., 2008a).
Intellectual Functioning
Clinical Definition. General intelligence describes an individual’s integration of verbal,
visuospatial, working memory, and executive processes (Lezak, Howieson, Bigler, & Tranel,
2012, pp. 22-23). Psychologists have adapted components from previous assessments, such as
the Stanford-Binet Test, as instruments to measure various brain functions (i.e., intelligence,
memory, reasoning). The intelligence quotient (IQ) was derived for clinical purposes to attach a
quantitative measure to intelligence. An IQ score is calculated by dividing the individual’s
mental age by the chronological age, and then multiplied by 100 (Kolb & Whishaw, 2015). On
current intelligence tests (e.g., Wechsler batteries), an average IQ for any given age is 100.
Approximately 68% of the population is described as having an average IQ score between 85
and 115. An IQ score above 115 is considered high average (14% of population), whereas a
score above 130 is superior (2% of the population). However, a below average IQ is any score
below 85 (14% of the population). Additionally, any IQ score below 70 is considered low (2% of
the population).
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Neuroanatomic Correlates. Intelligence has been associated with activity in the
dorsolateral and medial prefrontal cortex as well as the posterior parietal cortex (Kolb &
Whishaw, 2015, pp. 454-455; Song et al., 2008). Specifically, Jung and Haier (2007) reviewed
37 functional and structural neuroimaging studies and found elevated levels of activity in the
dorsolateral prefrontal cortex, inferior and superior parietal lobe, anterior cingulate, and select
regions within the temporal and occipital lobes when assessing for intelligence. The arcuate
fasciculus is a likely tract for connecting these brain regions. As a result, there is support for a
network view of intelligence. The strength of interactions and functional connectivity between
these brain regions are important predictive factors for intelligence (Song et al., 2008).
Developmental Models. While genetics accounts for approximately 50% of the
individual differences in intelligence, the other 50% is attributed to environmental factors such as
nutrition, gene mutations, socioeconomic status, or school quality (Sattler, 2008). Therefore,
children inherit genes that are related to intelligence, not a specific intelligence score. During
development, there is a considerable interaction between the brain and environment; therefore, it
is difficult to separate the influence of the environment and natural brain development (Sattler,
2008). Children experience significant developmental milestones between the ages of 18 and 24
months. They expand their language, increase formation of concepts, and develop the ability to
carry out symbolic functions at a highly rapid rate (Sattler, 2008). Therefore, intelligence test
scores do not start to become reliable indicators of future intelligence until around two years of
age. As children become older and go through grade school, IQ scores appear to be even more
correlated with scores obtained in adult years. Typically, IQ scores obtained after five years of
age tend to remain relatively constant due to the stability of genetic factors and the relative
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stability of the environment. However, unpredictable factors, such as epilepsy, may alter the
course of a child’s intellectual development.
Impact of Pediatric Epilepsy on Intellectual Functioning. Several studies have found
that 31-40% of the children diagnosed with epilepsy will exhibit low intelligence scores (IQ <
70) (Rantanen et al., 2011; Reilly et al., 2015). Furthermore, 18-24% of children diagnosed with
epilepsy will have extremely low intelligence scores (IQ < 50) (Berg et al., 2008a; Rantanen et
al., 2011; Reilly et al., 2015). When compared to normative controls, the percentage of children
with epilepsy falling below average cognition is elevated. The underlying epilepsy etiology, age
of onset, and seizure frequency are the most influential factors when determining the severity of
cognitive impairment (Berg et al., 2008a; Rantanen et al., 2011). Additional influences on
cognitive impairment found in childhood epilepsy include epilepsy duration, attentiondeficit/hyperactivity disorder (ADHD), and AED treatment itself (Berg et al., 2008a; Reilley et
al., 2015). Berg et al. (2008b) found children with idiopathic epilepsy scored significantly lower
than sibling controls on IQ measures. The IQ score differences were largely accounted by slower
processing speeds. On average, children with epilepsy scored 5.6 points lower than controls.
Further research done by Reilly and colleagues (2015) similarly found children with epilepsy
demonstrated significantly lower scores on measurements of processing speed, as well as
working memory. Specifically, being on polytherapy, having predominately generalized
seizures, and having ADHD were all independently associated with lower scores on the working
memory composite. Additionally, being on polytherapy, seizure onset prior to 24 months, having
ADHD, and having a developmental coordination disorder (DCD) were all independently
associated with lower scores on the processing speed composite. Jones, Siddarth, Gurbani,
Shields, and Caplan (2010) studied 91 children with epilepsy with average intelligence over two
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years. They found that those children with epilepsy who had uncontrolled seizures at baseline
(which those authors define as five or more seizures/year) were significantly more likely to have
a decline in their full-scale intelligence quotient (FSIQ) and performance intelligence quotient
(PIQ) over the two-year interval than the children with controlled seizures at baseline. The
baseline seizure variables such as age at onset, poor seizure control, and number of AEDs played
a minimal role in the decline of IQ scores in this sample. Additionally, it is important to note that
the majority of children with epilepsy have average intelligence; however, they are susceptible to
have specific cognitive deficits particularly in areas such as memory, language, attention and
concentration, executive functioning, or academic achievement (Prasher & Kerr, 2008).
Memory
Clinical Definition. Lezak and collegues (2012) defined memory as “the ability and
capacity to retain information and apply it for adaptive purposes” (p. 466). Long-term memory
storage and retrieval can be categorized into two different memory systems. A declarative system
(e.g., autobiographical and semantic memory) is conscious recollection of facts and events which
consists of personal experiences (Kolb & Whishaw, 2015; Squire, 1992). The second system is
the nondeclarative system (e.g., procedural memory) which is nonconscious procedural abilities
such as learned skills, conditioned reactions, and short-term events.
Neuroanatomic Correlates. Memory requires the functioning of many brain regions.
The connections of the medial temporal lobe (hippocampus, rhinal cortex), diencephalon
(hypothalamus, thalamus) structures, and prefrontal cortex are involved in declarative memory
(Kolb & Whishaw, 2015; Squire, 1992). There are two pathways in which the hippocampus
relays information throughout the brain (Kolb & Whishaw, 2015). The perforant pathway
connects the hippocampus to the posterior temporal cortex, whereas the fimbria fornix pathway
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connects the hippocampus to the thalamus, prefrontal cortex, basal ganglia, and hypothalamus.
Damage to the hippocampus has revealed that anterograde and episodic memories are impacted
more than retrograde and semantic memories. Additionally, autobiographical memory is
especially affected by damage to the hippocampus. Finally, the rhinal cortices are involved in
factual or semantic recognition. Nondeclarative memory involves brain areas involved in motor
control such as the cerebellum, basal ganglia (i.e., caudate nucleus, putamen, striatum),
amygdala, neocortex, and the motor cortex (Kolb & Whishaw, 2015; Squire, 1992). Specific
areas of the basal ganglia store specific nondeclarative memories. The caudate nucleus stores
instinctive actions, whereas the putamen stores procedural skills. Furthermore, the cerebellum is
involved with coordination and timing of these learned procedural skills.
Theoretical Models. Lezak et al. (2012) provided a three-stage model of memory. The
first stage is registration (sensory) memory which will hold large amounts of information for a
few seconds. During this brief time, a selection and recording process takes place. Information
that is selected to be registered is further processed as short-term memory. However, the
unregistered information quickly deteriorates. Immediate memory is the first stage of short-term
memory (STM) storage. Immediate memory retains information from the registration stage for
30 seconds or several minutes, until the information is transferred to a more permanent place.
Long-term memory (LTM) is the final step in memory consolidation. Storing information in
LTM can rapidly occur or continue for a period of time. LTM organizes information on the basis
of meaning and associations, whereas STM organizes information in terms of contiguity or
sensory information.
Another theoretical approach is Baddeley’s working memory model which
conceptualized memory as it relates to attention (Baddeley, 2010). Baddeley’s concept of
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working memory evolved from short-term memory. Working memory not only involves
temporary storage of information, but also the manipulation of that same information which is
necessary for complex cognitive tasks such as language comprehension, learning, and reasoning
(Baddeley, 1992). When coining the term “working memory,” Baddeley stressed that the role of
working memory is beyond that of simple storage of information (Baddeley, 2010). There are
four subsystems of Baddeley’s working memory: central executive, phonological loop,
visuospatial sketchpad, and episodic buffer (see Figure 2; adapted from Baddeley, 2010). The
central executive, which is mediated by the frontal lobe, is responsible for the coordination and
monitoring of the slave systems (i.e. visuospatial sketchpad and phonological loop) (Baddeley,
1992). It can be assumed to be a versatile attentional-controlling system rather than memory
storage. The phonological loop is the part of working memory that is responsible for the initial
processing and storage of verbal information. It consists of two components, a phonological store
and an articulatory control process. The phonological store is linked to speech perception and
can hold speech-based information for one to two seconds. The articulatory control process is
linked to speech production and circulates verbal information by subvocal repetition to register
them into the phonological store (Baddeley, 1992). The visuospatial sketchpad processes
nonverbal information. The slave systems can process their respected visual and verbal
information simultaneously; however, it can become difficult to process two visual or two verbal
tasks simultaneously due to interference of using the same system. Finally, the episodic buffer is
responsible for combining the visual and auditory information in order to link this information to
the episodic memory system (Baddeley, 2010).
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Figure 2
Baddeley’s Working Memory Model

Central Executive

Visuospatial
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Phonological
Loop

Visual
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Language

Note. Figure adapted from Baddeley, 2010.
Developmental Models. Children are more dependent on using the visuospatial
sketchpad for visual immediate memory due to their limited vocabulary to code the information
into a phonological form needed for storage in the phonological store (Gathercole, 1998). As the
child increases their language skills, visual material is gradually recoded into a phonological
form needed for the phonological loop. Around the age of seven, children begin to use a
rehearsal process to maximize auditory memory in the phonological store. Similar to visual
memory, auditory memory increases as children develop due to their expanding vocabulary. An
increase in vocabulary allows for better knowledge which enhances phonological loop
representations.
Neuropsychological Measures of Memory Functioning. Memory deficits can occur at
any stage of the memory process. Systematically examining different memory components can
help identify deficits at any given stage. The following testing procedures may be part of a
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neuropsychological memory battery: 1) Immediate recall to assess encoding; 2) Delay recall to
examine learning over time; 3) Interference is employed during the delay recall period to prevent
continuous rehearsal in temporary storage; 4) Learning by recognition, cueing, or saving
examines if poor recall is due to retention or retrieval deficits (Lezak et al., 2012). Common
assessments to measure memory include: Digit Span Forwards (DSF) from the Wechsler
Intelligence Scales; NEPSY; Wechsler Memory Scale (WMS); Wide Range Assessment of
Memory and Learning (WRAML); The Children’s Memory Scale (CMS); and The California
Verbal Learning Test (CVLT) (Davis, 2011; Lezak et al., 2012).
Impact of Pediatric Epilepsy on Memory. Memory difficulties is one of the most
common complaints of individuals diagnosed with epilepsy (Prasher & Kerr, 2008). Children
with epilepsy frequently demonstrate memory impairment when compared to controls (Rzezak et
al., 2012; Sepeta et al., 2017). Specifically, a recent review article by Menlove and Reilly (2015)
found that the majority of studies (78%) report lower memory performance for children with
epilepsy when compared to controls and normative scores. Sepeta et al. (2017) examined the
memory of 70 children with focal epilepsy and 70 healthy controls. Verbal and visual delayed
free recall (CVLT-C, CMS Dot Locations, and WRAML Story Memory) was significantly lower
among the children epilepsy performed than the healthy controls. However, there were no
significant differences regarding recognition between the epileptic children and controls (Sepeta
et al., 2017; Williams et al., 2001). When assessing learning and memory, children with epilepsy
demonstrate intact learning efficiency (List A, Trial 5; Semantic Clustering; Recall Consistency)
and new learning (Total Trials) on the CVLT-C (Sepeta et al., 2017; Williams et al., 2001).
Williams and colleagues (2001) found children with epilepsy performed better with regards to
short-term recall as compared to long-term delayed recall on the CVLT-C.

20
Seizure Severity and Memory Function. Predictors of memory impairment include a
greater number of AED’s used and increased seizure frequency (Menlove & Reilly, 2015).
Additionally, the earlier age of seizure onset (Lopes et al., 2014; Fuentes & Smith, 2015) and
longer duration of epilepsy (Lopes et al., 2014; Nolan et al., 2004) are related to poor memory
performance. These factors have previously been reported to be associated with global cognitive
difficulties as well; therefore, it is difficult to distinguish if their impact on memory is in addition
to that of their impact on global cognitive functioning (Menlove & Reilly, 2015).
Executive Functioning
Clinical Definition. Gioia and colleagues (2000a) define executive functioning (EF) as a
domain of cognitive functioning which encompasses the eight components of inhibition, shifting,
emotional control, initiation, working memory, planning, organization, and self-monitoring.
Inhibition is described as the ability to restrain the impulsive thoughts and actions of oneself.
Shifting is the ability to think flexibly and transition easily from one situation to another.
Emotional control is the ability to modulate emotional responses in an adaptive manner.
Initiation is described as the ability to independently start a task and problem solve as well as
independently generate ideas and responses. As described earlier, working memory is the
capacity to temporary store information and manipulate that same information. Planning is the
ability to manage subsequent tasks. Organization is described as the ability to impose order on a
variety of tasks. Finally, self-monitoring is the ability to review the performance of oneself and
compare it against an expected standard. Many cognitive tasks require children to employ two or
more of these executive functioning components (Davis, 2011).
Neuroanatomic Correlates. The association between executive functioning and the
frontal lobes is vast (Godefroy, 2003; Lezak et al., 2012) and the terms “frontal lobe functions”
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and “executive functions” are often used interchangeably (Anderson, 1998; Kolb & Whisaw,
2015). Specifically, the use of functional neuroimaging has confirmed activation of the prefrontal
cortex (PFC) during EF tasks such as the Tower of London (Baker et al., 1996). While the frontal
lobe mediates the majority of EF skills, other brain areas are also necessary for intact EF
(Anderson, 1998). The prefrontal cortex is dependent on the interaction with a variety of other
brain areas such as the brain stem, occipital, temporal, and parietal lobes, as well as limbic and
subcortical regions (Godefroy, 2003; Stuss & Beson, 1984).
Developmental Models. Executive processes continue to develop throughout childhood
and adolescence as the frontal lobes, which mediate the majority of EF skills, continue to
develop until late adolescence or early twenties (Davis, 2011; Lezak et al., 2012). The
development of EF typically occurs in stages or spurts throughout childhood and adolescence
(Anderson, 1998; Anderson, 2002). As young as 12 months of age, infants begin to demonstrate
frontally mediated behaviors such as goal-direction and planning (Anderson, 1998). Simple
planning skills and generating new concepts are more pronounced around four years of age
(Anderson, 2002). As the child develops, planning and organizational skills develop rapidly from
seven to 10 years of age. Searching in an organized manner and hypothesis testing appear to
reach adult levels around the age of 10, whereas planning does not reach adult levels until the
age 12 (Anderson, 1998). Regarding inhibition, most infants at 12 months begin to inhibit certain
behaviors. By three years of age, children are able to adequately inhibit most instinctive
behaviors (Anderson, 2002; Davis, 2011). Furthermore, there are significant improvements in
overall impulse control at six years of age and will typically reach adult levels by the age of 12
(Anderson, 1998; Anderson, 2002; Davis, 2011). As children and adolescents develop, their
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memory capacity, language skills, and processing speed increase which aids in their ability to
function on measures of executive functioning (Anderson, 1998).
Neuropsychological Measures of Executive Functioning. Executive dysfunction can
occur at any stage of intentional behavior. Systematically examining these EF components can
help identify at which stage(s) executive dysfunction occurs (Lezak et al., 2012). Common
assessments to measure EF include: Delis-Kaplan Executive Function System (D-KEFS),
Behavior Rating Inventory of Executive Function (BRIEF), Wisconsin Card Sorting Test
(WCST), Tower of London - Drexel Version (TOL-DX), Stroop Color-Word Test (Stroop),
Trail-Making Test Parts A and B (TMT), and Digit Span Forwards Backwards (DSB) from the
Wechsler Intelligence Scales (Davis, 2011; Lee, 2010; Lezak et al., 2012). Performance based
measures, such as the WCST or TOL-DX, may not always be sensitive to executive dysfunction
due to the limited need for self-initiated organization and problem solving when placed in a
structured and quiet individual testing environment (Sherman, Daniel, & Eyrl, 2006). The use of
the BRIEF has demonstrated clinical and empirical importance for a variety of diagnostic
subgroups such as ADHD, frontal lobe lesions, and mental retardation (Gioia, Isquith, Guy, &
Kenworthy, 2000b).
Impact of Pediatric Epilepsy on Executive Functioning. EF deficits are frequently
found in children diagnosed with epilepsy (MacAllister, Vasserman, Rosenthal, & Sherman,
2014). Furthermore, significant executive dysfunction has been found among children with
epilepsy when compared to normal controls, which will be discussed in the following paragraphs
(Høie et al., 2008; Luton, Burns, & DeFilippis, 2010; Parrish et al., 2007). Similar to other
cognitive disturbances in epilepsy, greater executive dysfunction is seen with earlier age of
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onset, polytherapy, seizure frequency, and longer seizure duration (Høie et al., 2008; MacAllister
et al., 2014).
Executive Functioning Assessment in Pediatric Epilepsy Using Performance Based
Measures. Performance based EF measures have demonstrated more frequent executive
dysfunction in children with epilepsy compared to normative controls (Høie et al., 2008; Longo,
Kerr, & Smith, 2013; MacAllister et al., 2012a). Høie and colleagues (2008) found EF deficits
(31%) on the WCST to be more common among children with epilepsy than compared to normal
controls. In another study, MacAllister and colleagues (2012a) studied 90 children with epilepsy
(62% focal seizures, 28% generalized seizures, and 10% mixed presentation). The epileptic
children showed significantly lower scores on the TOL-DX. The most frequently impaired scores
were as follows: rule-violation errors (57%), total problem-solving time (44%), total moves
(43%), and total correct (11%). Additionally, Longo and colleagues (2013) found children with
epilepsy performed significantly lower on attention and working memory measures (i.e., DSF
and DSB) compared to the normative sample. Earlier age of onset, number of AEDs, seizure
frequency, and duration have been found to correspond with more severe executive dysfunction
on performance-based EF measures (MacAllister et al., 2012a; Riva et al., 2005). However,
seizure type was not found to be associated with performance-based EF measures (MacAllister et
al., 2012a).
Executive Functioning Assessment in Pediatric Epilepsy Using the BRIEF. The use of
EF rating scales is limited among the pediatric epilepsy population. Among the few studies, there
appears to be significantly more executive function problems elevated on the BRIEF among the
children with epilepsy than in the normative and control samples (Love et al., 2016; MacAllister
et al., 2012a; Parrish et al., 2007; Sherman, Daniel, & Eyrl, 2006; Slick, Lautzenhiser, Sherman,
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& Eyrl, 2006). Specifically, 68% of epileptic children significantly elevated at least one BRIEF
scale, 36% had four or more significantly elevated scales, and approximately 23-33% had six or
more significantly elevated scales (Love et al., 2016; Slick et al., 2006). The Working Memory
subscale (Love et al., 2016; MacAllister et al., 2012a; Parrish et al., 2007; Sepeta et al., 2017;
Slick et al., 2006) and the Metacognition Index (MI) (Love et al., 2016; MacAllister et al.,
2012a) was the most frequently elevated scale and index, respectively, among children with
epilepsy. Sherman et al. (2006) found that 45% had clinically significant EF impairments as
defined on the Global Executive Composite (GEC) scale. In contrast, some studies found only
subclinical GEC elevations (Love et al., 2016; MacAllister et al., 2012a).
Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common
neurodevelopmental disorders in children. Approximately 5-7% of children are diagnosed with
ADHD globally (American Psychiatric Association [APA], 2013; Millichap, 2011; Thomas et
al., 2015) where boys are two to six times more likely to be diagnosed than girls (APA, 2013;
Millichap, 2011; Thapar & Cooper, 2016; Willcutt, 2012). ADHD is highly comorbid with
numerous other diagnoses such as autism spectrum disorder, communication or learning
disorders, anxiety or mood disorders, oppositional defiant disorder, intellectual disability, and
epilepsy (Davis, 2011; Millichap, 2011; Parisis, Moavero, Verrotti, & Curatolo, 2010; Thapar &
Cooper, 2016).
Clinical Definition and Types. ADHD originates in childhood and is characterized by
impaired functioning in the domains of inattention and/or hyperactivity/impulsivity (Davis,
2011). Inattention in ADHD can be described as difficulty sustaining focus, disorganization,
making careless mistakes, or becoming easily distracted. Hyperactivity in ADHD refers to
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excessive energy, fidgeting, tapping, or talking. Additionally, impulsivity in ADHD is described
as completing actions without planning or thinking such as blurting out answers, difficulty
waiting turn, or constant interruptions/intrusions on others (APA, 2013). Several of these
symptoms must be present prior to age 12 and for at least six months for a diagnosis of ADHD.
ADHD can be divided into three subtypes. Combined type (ADHD-C) children experience both
symptoms of inattention and hyperactivity/impulsivity, whereas the predominantly inattentive
type (ADHD-I) and the predominantly hyperactivity/impulsivity type (ADHD-H) experience
symptoms of only one domain. In a review of literature, Willcutt (2012) found that the ADHD-I
was the most common subtype diagnosed across the majority of grade school children and
adolescents. However, among preschool children, ADHD-H subtype was most common. Many
children will experience excessive motor activity prior to age four; however, ADHD symptoms
are difficult to distinguish from the highly normative energetic child at that young of age (APA,
2013). Therefore, ADHD is most often identified in elementary school where children’s
inattention and hyperactivity/impulsivity become increasingly apparent and detrimental.
Hyperactivity/Impulsivity typically decrease by adolescence; however, underlying attention
difficulties will likely persist throughout the lifespan for individuals diagnosed with ADHD
(Davis, 2011).
Pediatric Etiology.
Genetic. ADHD is found to be influenced by both genetic and environmental factors. By
researching adoption and twin studies, ADHD has been found to be highly heritable, ranging
from 70% to 90% (APA, 2013; Ben Amor et al., 2005; Bush, 2010; Davis, 2011). Nikolas and
Burt (2010) completed a meta-analysis of twin studies and found ADHD heritability accounted
for 71% and 73% of the variance in ADHD-I and ADHD-H, respectively. Additionally,
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Biederamn and colleagues (1995) found the risk of ADHD among children of ADHD parents to
be 57%.
Medical Risk Factors. Although genetic factors are considered to be the most influential
factor of ADHD, 10% to 25% of the variance in twin ADHD has been accounted by
environmental factors (Gustafson, 2010). Environmental risk factors which have been found to
be relevant for the prognosis of ADHD include: prematurity, low birth weight, maternal age,
fetal stress, or in utero exposure to alcohol or smoking (APA, 2013; Davis, 2011; Gustafson,
2010).
Neuroanatomical Correlates. Numerous brain areas appear to be affected such as the
cortex, white matter, basal ganglia, and cerebellum (Davis, 2011; Mahone et al., 2011). Bilateral
caudate volumes in children with ADHD are found to be significantly reduced (Mahone et al.,
2011). Specifically, a significant predictor of hyperactive/impulsive severity was correlated to
significant right caudate volume loss and moderate-to-large left caudate volume loss. Children
with ADHD, ages 9 to14 years, showed the most pronounced right caudate volume loss.
However, these reduced caudate volumes often normalize by puberty in children with ADHD
which coincides with reduced hyperactive/impulsive symptoms during adolescence.
Additionally, Shaw and colleagues (2007) found the cortical development in ADHD children
was significantly delayed by several years compared to that of normative children. Specifically,
10.5 years was the average age of the ADHD sample when 50% of the cortex reached peak
thickness, as compared to an average of 7.5 years for typically developing controls. The
prominent cortical delay was in the superior and dorsolateral prefrontal regions. The significance
of delayed prefrontal cortex development and caudate reduction in the research described is that
these areas are responsible for numerous cognitive functions such as inappropriate
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responses/thoughts suppression, attention control, goal directed behaviors, motor control, and
working memory (Grahn, Parkinson, & Owen, 2008; Kolb & Whishaw, 2015; Shaw et al.,
2007). Deficits seen in these cognitive functions have all been associated with the diagnosis of
ADHD.
Neurophysiological Mechanisms. Two neurotransmitter (NT) systems have been shown
to be associated with ADHD: dopamine (DA) and norepinephrine (NE). DA plays a critical role
in the central nervous system for coordinating movement, attention and learning, alertness, and
motivation (Kolb & Whishaw, 2015). ADHD individuals have been found to have excess DA
transporters in the striatum and consequently, have lower than normal DA levels in the synapses
(Sagvolden, Johansen, Aase, & Russel, 2005; Spencer et al., 2005). NE has been also found to
play a role in the central nervous system for concentration, inhibition, and perseverance (Kolb &
Whishaw, 2015). The role of NE in ADHD has not been studied as extensively as DA (Frank,
Scheres, & Sherman, 2007). However, medications that block NE transporters in the cortex,
which increases NE cortical levels, have been found to improve ADHD symptoms (Swanson et
al., 2006).
Impact of ADHD on Intelligence. Intellectual functioning among children diagnosed
with ADHD has been found to be significantly lower than children without ADHD; however,
still within average cognitive functioning (Gomez, Vance, & Watson, 2016; Weiss, Saklofske,
Holdnack, & Prifitera, 2016). The cognitive deficits in ADHD are typically associated with
deficits in EF skills (Weiss et al., 2016). When assessing intelligence, ADHD children have been
reported to perform poorly on measures tapping into the components of attention, EF, and
processing speed (Gomez et al., 2016; Weiss et al., 2016). Relevant Wechsler intelligence
subtests assessing these aspects include: Digit Span (auditory working memory), Coding
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(graphomotor processing speed measure), and Symbol Search (measure of processing speed).
Studies have found significantly lower scores among the ADHD children than the normative
controls on Wechsler subscales such as Letter-Number Sequencing, Arithmetic, Vocabulary,
Picture Completion, Coding, and Symbol Search (Gomez et al., 2016; Weiss et al., 2016).
Furthermore, significantly lower scores were found on the Working Memory Index (WMI),
Processing Speed Index (PSI), and FSIQ compared to the control group (Weiss et al., 2016).
Impact of ADHD on Memory Functioning. Attention and concentration can
significantly affect memory (Lezak et al., 2012). As a result, memory difficulties can be related
to poor selective attention, distractibility, as well as organization of information at encoding all
of which are the criteria for ADHD (Davidson et al., 2006; Lezak et al., 2012; Mahone &
Schneider, 2012). Memory difficulties typically occur when ADHD children are exposed to
elevated levels of external stimuli and they have problems recalling information due to their
inability to organize and encode information efficiently (Lezak et al., 2012). Cutting, Koth,
Mahone, and Denckla (2003) compared verbal learning and memory with the CVLT-C in
children with ADHD and healthy controls. Despite initially learning the same number of words
and utilizing the same learning strategies (i.e., semantic clustering, serial clustering, and middle
region) as the control group, the ADHD children had significantly lower scores when recalling
the words freely and cued after delays. In another study, Lee and colleagues (2015) compared the
memory profiles of children with ADHD and healthy controls using the CMS. Children with
ADHD performed similarly to the healthy controls on the short-term and long-term CMS
memory measures. However, the ADHD children performed slightly below the healthy controls
on Dot Locations Learning.
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Impact of ADHD on Executive Functioning. Deficits across multiple components of
executive functioning (EF) are often found in individuals diagnosed with ADHD (Davis, 2011;
Willcutt et al., 2005). When compared to normative samples, studies have found the strongest
and most consistent EF deficits in ADHD individuals were on assessments measuring inhibition,
vigilance, working memory, motivation, motor control, and planning (Barkley, 1997; Willcutt et
al., 2005). Toplak, Bucciarelli, Jain, and Tannock (2008a) compared adolescents with ADHD
and healthy controls on parental and teacher BREIF ratings. Compared to the healthy controls,
the adolescents with ADHD displayed significantly elevated scales (i.e., Inhibit, Shift, Working
Memory, and Plan/Organize subscales) in both parent and teacher ratings. The Working Memory
subscale was the most significantly elevated scale. Regarding performance-based EF measures,
Culbertson and Zillmer (1998) examined the TOL-DX among two different age groups of
ADHD children (7-9 years and 10-12 years) and normal controls. Both ADHD group’s planning
and problem-solving performance (total move score) were significantly different compared to the
normal controls. On average, the ADHD children employed 17-25 additional total moves.
Furthermore, the younger ADHD group demonstrated significantly more time violations, while
the older ADHD group appeared to have subclinical elevations compared to the normal controls.
Finally, both ADHD groups demonstrated inhibition deficits in which they exhibited more rule
violations than the normal control.
Treatments for ADHD. Medication and behavior therapy are the most commonly used
treatments for ADHD. There are a number of different medications to help regulate ADHD
symptoms which include: stimulants (e.g., methylphenidate, amphetamine), selective
norepinephrine reuptake inhibitor (i.e., atomoxetine), and other psychotropic medications such as
guanfacine, clonidine, or buproprion (Davis, 2011). Stimulants have been found to be very
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effective for the treatment of ADHD because they increase synaptic DA either by blocking DA
transporters or increasing the release of DA from presynaptic terminals (Swanson et al., 2013).
Despite medication being rather effective, research suggests that approximately 20-30% of
children will be unresponsive to medication (Toplak et al., 2008b). Behavior therapy is an
alternative treatment or can be used in tandem with medication. Interventions used with parents
and teachers (e.g., seating at front of classroom, limit distractions) are proven to be effective
(Davis, 2011). However, it is suggested a multimodal treatment is the most beneficial. The
Multimodal Treatment of ADHD Cooperative Group (MTA; 2004) found children receiving
ADHD medication, with behavior therapy or even alone, showed significantly reduced ADHD
symptoms compared to children only receiving behavior therapy. Additionally, children in the
combination group (medication and therapy) exhibited similar results at a significantly lower
medication dosage than children in the medication only sample. Each individual can experience
ADHD symptoms differently, depending on the type, severity, and etiology of the disorder.
Relationship Between ADHD and Childhood Epilepsy
Incidence of ADHD in Epilepsy. ADHD is one of the most common comorbid disorders
among children diagnosed with epilepsy. Studies have shown ADHD prevalence estimates range
from 12% to 49% in children with epilepsy (Dunn et al., 2003; Hermann et al., 2007; Kang et al.,
2015; Reilly, 2011) as compared to the general population (5%) (APA, 2013) and normative
controls (6%) (Hermann et al., 2007). Specifically, the inattentive subtype (ADHD-I) is
especially common among children with epilepsy (Hermann et al., 2007; MacAllister et al.,
2012b; Reilly, 2011). However, it is difficult to distinguish whether ADHD develops as a result
of epilepsy or it is an unrelated disorder that often is comorbid (Dunn et al., 2003). Regardless of
the etiology, 82% of children with epilepsy displayed ADHD symptoms prior to their epilepsy
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diagnosis (Hermann et al., 2007). Children with comorbid epilepsy and ADHD are at higher risk
for elevated levels of cognitive deficits than children with epilepsy alone (Reilly, 2011).
Impact of Comorbid Epilepsy and ADHD on Memory Functioning. Lee et al. (2016)
has been the only study that has examined the specific memory deficits of children with
comorbid epilepsy and ADHD. They examined 149 children (42 healthy controls; 42 focal
epileptics; and 23 epileptic/ADHD) using the CMS core subtests and the supplemental Picture
Locations subtest. Children with comorbid epilepsy/ADHD demonstrated deficits consistent with
both epilepsy and ADHD alone such as significantly lower scores on tasks measuring sustained
attention and visual-spatial span compared to healthy controls. However, the comorbid group
appeared to have compounded effects in that they had the greatest deficits on all the measures
assessed as compared to the epilepsy and ADHD groups.
Impact of Comorbid Epilepsy and ADHD on Executive Functioning. Similarly, there
has been limited studies which have examined the effects of comorbid epilepsy and ADHD on
EF (Kang et al., 2015; MacAllister et al., 2012b). MacAllister and colleagues (2012b) examined
executive functioning differences between ADHD-I (n=22), ADHD-C (n=23), epilepsy/ADHD-I
(n=31), and epilepsy/ADHD-C (n=15). The comorbid groups demonstrated significant deficits
on measures of auditory attention (Wechsler DSF) and working memory (Wechsler DSB)
compared to the ADHD groups. There were additional differences across the groups were also
seen on the Conners’ Continuous Performance Test - second edition (CPT-2). The
epilepsy/ADHD-I group demonstrated slower average response speeds (Hit Rate) than their
counterpart ADHD-I group. Furthermore, the epilepsy/ADHD-C group employed moderately
more perseverations (anticipatory responses) and omission errors as compared to the ADHD-C
group. Similarly, Kang et al. (2015) examined 61 children with epilepsy and 59 children with
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comorbid ADHD and epilepsy using the Comprehensive Attention Test (CAT) to evaluate
attention/executive function. Omission error scores on sustained attention and flanker
(interference) tasks, and scores on the spatial working-memory forward and backward tasks were
significantly lower in the comorbid group than in the epileptic counterparts.
Role of Executive Functioning in Memory
As described previously, there has been prior research on both memory and EF tasks
among children with epilepsy; however, there has been very limited studies which have
examined the relationship between these two cognitive domains. The relationship between
memory and EF has been demonstrated in other neurological disorders such as traumatic brain
injury (TBI) (Duff, Schoenberg, Scott, & Adam, 2004; Mandalis, Kinsella, Ong, & Andreson,
2007). Duff and colleagues (2004) studied 212 adults comprising of the following neurological
or psychiatric conditions: head injury, dementia, vascular disorders, neoplasms, depression, and
pain disorder. The study indicated visual and verbal memory (WMS select subtests, Rey
Auditory Verbal Learning Test (RAVLT), and Rey-Osterrieth Complex Figure Test (ROCFT))
shared 55-60% of the variance with executive functioning (TMT Part B and WCST). An
additional study completed by Mandalis et al. (2007) studied memory deficits in 36 TBI children
using Wechsler’s DSF, TOL, Controlled Word Association Test (COWAT), Animal Fluency,
and RAVLT. The TBI children demonstrated significantly lower scores compared to the healthy
controls on the attention task (DSF) and the majority of EF tasks (TOL, COWAT, and Animal
Fluency). Across the learning and delayed recall phases of the new learning task (RAVLT), the
TBI group produced significantly fewer words than the healthy controls. The attention task
(DSF) and EF tasks were significantly correlated with free recall and recognition on the RAVLT
in the TBI group.
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There have been only two previous studies that have examined the association between
memory and executive dysfunction in pediatric epilepsy (Rzezak et al., 2012; Sepeta et al.,
2017). Rzezak and colleagues (2012) examined 36 children with TLE and 28 healthy controls on
measures of memory, learning, attention, mental flexibility, and mental tracking. The
neuropsychological battery consisted of the Wide Range Assessment of Memory and Learning
(WRAML), TMT, WCST, and Category Fluency. The TLE children with the most severe EF
deficits exhibited the lowest performance in verbal and visual learning and memory tests
(WRAML Picture Memory, Design Memory, Story Memory immediate and delayed recall,
Sentence Memory, and Verbal Learning). Sepeta et al. (2017) examined 70 children with focal
epilepsy and 70 healthy controls. It was found that working memory (measured by BRIEF
Working Memory and DSB) predicted 9-19% of the variance in delayed free recall for verbal
(CVLT-C; WRAML Story Memory) and visual memory (CMS Dot Locations subtest).
Additionally, the Planning/Organization scale from the BRIEF predicted 9-10% of the variance
in verbal memory (CVLT-C; WRAML Story Memory). These two initial studies support the role
of executive functioning in memory retrieval, suggesting that executive dysfunction negatively
impacts memory in children with epilepsy.
Purpose and Hypotheses

It is well known that epilepsy and ADHD children are vulnerable to both EF and memory
difficulties. However, the evidence for the impact of EF on memory is very limited with only
two studies to date focusing on this association (Rzezak et al., 2012; Sepeta et al., 2017).
Additionally, these studies looked at homogeneous samples of pediatric epilepsy (focal and
temporal lobe epilepsy) and no study has taken into account highly comorbid disorders, such as
ADHD. The interaction between EF and memory is important to consider as EF impairments
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may put children at risk for experiencing memory difficulties which can impact their academic
performance and quality of life.
This will be the first study to research the impact of executive dysfunction on memory in
the pediatric epilepsy and ADHD population. Evaluation of the relationship between EF as
measured by the BRIEF and memory as measured by the CVLT-C and CMS in four groups of
children (i.e., intractable epilepsy, controlled epilepsy, comorbid epilepsy/ADHD, and ADHD)
will be conducted. Additionally, this study will investigate the relationship of epilepsy variables
(e.g., age of onset, AED’s, seizure frequency, epilepsy type) and intelligence with EF and
memory variables of the children with epilepsy, as these variables have been found to have an
impact on both EF and memory domains (Berg et al., 2008a; Rantanen et al., 2011; Reilley et al.,
2015; Shomakhova et al., 2012).
The following hypotheses will be tested:
1. Children with epilepsy will demonstrate a lower memory performance on the CMS and
CVLT-C compared to children with ADHD.
2. The comorbid epilepsy and ADHD group will demonstrate significantly reduced memory
performance compared to the other groups.
3. There will be a different memory profile among the two groups. Specifically,
a. The epilepsy group will show average recognition and learning efficiency, but a
lower learning slope, total word recall, and immediate and delay recall scores.
b. In contrast, the memory profiles of the ADHD group will exhibit average overall
memory, and they will exhibit greater difficulty with initial attention and
increased susceptibility to interference.
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4. Reduced memory performance on the CMS and CVLT-C will be related to greater
executive dysfunction as measured by the BRIEF.
5. Global intelligence (FSIQ), global executive functioning (BRIEF GEC), and age of
seizure onset will be significant predictors of memory function in the epilepsy
participants.
6. Global intelligence (FSIQ) and global executive functioning (BRIEF GEC) will be
significant predictors of memory function in ADHD participants.
In addition to these hypotheses, exploratory analyses will be calculated to examine the
relationship between seizure variables (e.g., seizure frequency, number of failed AED’s, age of
onset), neuropsychological assessment variables, and clinical impairments on the BRIEF.
Method
Participants
Participants were collected from 220 subjects who were consecutively referred to Florida
Hospital for Children for an epilepsy and/or ADHD evaluation. Of these, 104 patients met the
following inclusion criteria:
1) Participants were between the ages of 5 and 18 years at the time of baseline
neuropsychological assessment.
2) The epileptic participants were diagnosed by an epileptologist following a clinical
interview, neurological evaluation, and electroencephalography (EEG).
3) The ADHD participants were diagnosed by a neuropsychologist following a clinical
interview and neuropsychological testing.
4) Participants completed all of the following assessments in their entirety: Wechsler
Intelligence Scale for Children - Fourth Edition (WISC-IV) and/or Wechsler Abbreviated
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Scale of Intelligence - Second Edition (WASI-II); California Verbal Learning Test Children’s Version (CVLT-C); and Children’s Memory Scale (CMS) Dots, Stories, and
Faces subtests.
5) Participants obtained a Full-Scale Intelligence Quotient (FSIQ) > 55 (three standard
deviations below mean).
6) Participant’s parent or legal guardian completed the Behavior Rating Inventory of
Executive Function (BRIEF) questionnaire.
7) Participants did not have a history of a traumatic brain injury (TBI).
Participant Demographics. Participants were primarily Caucasian (n=63), followed by
Hispanic/Latino (n=23), African American (n=10), Mixed race (n=4), and other or missing
(n=4). Ethnicity was primarily Non-Hispanic (n=79). Additionally, most of the participants were
monolingual English speakers (n=83), with the remaining participants being bilingual
English/Spanish speakers (n=15), one English/other language bilingual speaker, or missing
information (n=5). Participants were evenly distributed in terms of sex with females and males
each making up 50% (n=52) of the total sample. The mean age of the total sample was 10.18
(SD=2.87) and the mean years of education of 4.17 (SD=2.81).
Diagnostic Group Demographics. The total sample was first divided into two groups
which consisted of an overall epilepsy group and a pure ADHD group. Following initial analyses
of the overall epilepsy and ADHD groups, the epilepsy group was then subdivided into three
separate groups which consisted of an intractable epilepsy group, well controlled epilepsy group,
and comorbid epilepsy/ADHD group. Secondary analyses were completed to detect differences
between the three diagnostic epilepsy groups and the ADHD group. Refer to Table 2 for
demographics regarding diagnostic groups.
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Table 2
Demographic Characteristics of Diagnostic Groups within the Total Sample

Demographic

ADHD

Epilepsy

Intractable
Controlled
Comorbid
n
30
74
17
42
15
Age
M
9.23
10.57
11.00
10.45
10.40
SD
2.21
3.02
2.65
3.18
3.11
Range
6-16
6-16
6-15
6-16
7-15
Sex
Male
18
34
6
19
9
Female
12
40
11
23
6
Handedness
Right
29
60
15
32
13
Left
1
14
2
10
2
Note. Intractable, Controlled, and Comorbid diagnostic groups are the subsets of the Epilepsy
group.
Epilepsy and ADHD diagnostic group age differences were assessed utilizing a MannWhitney U test and showed there were no significant differences, U = 855, p = .065, between the
two diagnostic groups. Groups additionally did not differ by sex, χ2(1) = 1.69, p = 0.194, or
handedness, χ2(1) = 4.20, p = 0.051. Similarly, when the epilepsy group was divided into three
diagnostic groups, there were no significant age differences, χ2(3) = 4.34, p = 0.227, between the
four diagnostic groups. Groups additionally did not differ by sex, χ2(3) = 3.62, p = 0.306, or
handedness, χ2(3) = 6.04, p = 0.110.
Epilepsy Group Demographics. For each child diagnosed with epilepsy, several
epilepsy variables were documented, including age of seizure onset, time since seizure onset
(i.e., duration of epilepsy disorder), number of antiepileptic drugs (AED’s), number of failed
AED’s, and seizure type (i.e., focal, generalized, or mixed). For the children diagnosed with
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focal seizures, the side and location of the seizures were also obtained. Tables 3 and 4 further
demonstrate demographic and clinical characteristics of the epilepsy sample.
Table 3
Means, SDs, and Min/Max for Epilepsy Variables of the Epilepsy Groups
Variables

Epilepsy

Intractable

Age at seizure onset
M
6.19
6.62
SD
4.07
3.54
Min/Max
0 / 15.17
1 / 13
Time since seizure onset
M
4.68
4.76
SD
3.37
2.57
Min/Max
0 / 15
0 / 10
Number of AEDs
M
1.12
1.31
SD
.73
.60
Min/Max
0/3
1/3
Number of failed AEDs
M
1.13
3.31
SD
1.84
1.92
Min/Max
0/8
1/8
Note. Age and time since seizure onset are shown in years.

Controlled

Comorbid

6.71
4.45
0 / 15

4.35
3.20
0 / 12.00

3.95
3.61
0 / 15

6.47
2.97
2 / 12

.81
.59
0/3

1.80
.68
1/3

.05
.22
0/1

1.57
1.96
0/8
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Table 4
Clinical Characteristics of the Epilepsy Groups

Epilepsy

Intractable
Controlled
Comorbid
Seizure Type
Focal
30 (40.5%)
13 (76.5%)
7 (16.7%)
10 (66.7%)
Generalized
9 (12.2%)
3 (17.6%)
1 (2.4%)
5 (33.3%)
Missing Data
35 (57.3%)
1 (5.9%)
34 (81.0%)
0 (0.0%)
Number of AEDs
None
11 (14.9%)
0 (0.0%)
11 (26.2%)
0 (0.0%)
One
46 (62.2%)
12 (70.6%)
29 (69.0%)
5 (33.3%)
Two
12 (16.2%)
3 (17.6%)
1 (2.4%)
8 (53.3%)
Three or more
4 (5.4%)
1 (5.9%)
1 (2.4%)
2 (13.3%)
Side of focal seizure onset
Right
16 (21.6%)
4 (23.5%)
9 (21.4%)
3 (20.0%)
Left
20 (27.0%)
6 (35.3%)
7 (16.7%)
7 (46.7%)
Bilateral
14 (18.9%)
4 (23.5%)
5 (11.9%)
5 (33.3%)
R>L
1 (1.4%)
1 (5.9%)
0 (0.0%)
0 (0.0%)
Location of focal seizure onset
Multilobar
18 (24.3%)
7 (41.2%)
3 (7.1%)
8 (23.3%)
Frontal
8 (10.8%)
3 (17.6%)
2 (4.8%)
3 (20.0%)
Temporal
11 (14.9%)
3 (17.6%)
4 (9.5%)
4 (26.7%)
Parietal
4 (5.4%)
1 (5.9%)
3 (7.1%)
0 (0.0%)
Occipital
2 (2.7%)
1 (5.9%)
1 (2.4%)
0 (0.0%)
Note. The side and location of the seizures were obtained for children diagnosed with focal
seizures.
Location of Treatment
Florida Hospital Orlando has a Level 4 Epilepsy Center. According to the National
Association of Epilepsy Centers (NAEC), a Level 4 center provides more extensive
neurodiagnostics monitoring, as well as medical, neuropsychological, and psychosocial
treatment. Additionally, Level 4 centers also offer a complete epilepsy surgery evaluation,
including intracranial electrodes and numerous surgical procedure options for epilepsy. The
study was approved by the Florida Hospital for Children – Comprehensive Pediatric Epilepsy
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Center Institutional Review Board. Informed consent was obtained prior to the evaluation by a
member of the research team.
Measures
Wechsler Intelligence Scales. The Wechsler Intelligence Scale for Children - Fourth
Edition (WISC-IV) (Wechsler, 2003) was used to evaluate intellectual functioning in the
majority (89%) of the children ages 6 to 16. However, some of the children (11%), ages 13 to 16,
were evaluated by the Wechsler Abbreviated Scale of Intelligence - Second Edition (WASI-II)
(Wechsler, 2011) in addition with the WISC-IV subtests comprising the working memory
(WMI) and processing speed (PSI) indexes. The utilization of the WASI-II/WISC-IV
combination was for ease of intelligence assessment comparison when children returned for a
reevaluation after the age of 16 (the WISC-IV age cut-off).
California Verbal Learning Test - Children’s Version (CVLT-C). The California
Verbal Learning Test - Children’s Version (Delis, Kramer, Kaplan, & Ober, 1994) measures
performance level and strategic adaptation of verbal learning and memory in children ages 5 to
16. The CVLT-C consists of a 15-word list (five words from three semantic categories)
presented over five learning trials with immediate recall after each trial. Next, a second 15-item
interference word list with immediate recall is given which is then followed immediately by free
and cued delay of the original learning list. After a 20-minute delay, a long-delay free-recall, and
a cued-recall with yes/no recognition of the original list are administered. See variable
descriptions in Table 5. Previous research has shown the validity and reliability of the CVLT-C
in children with epilepsy and/or ADHD (Muir-Broaddus, Rosenstein, Medina, & Soderberg,
2002; Sepeta, et al., 2017; Williams, et al., 2001).
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Table 5
CVLT-C Variable Descriptions
Description

Variable

Initial Attention

List A Trial 1 and List B

Learning Efficiency

Semantic Clustering

Learning Slope

List A Trial 5

Immediate Delay Free Recall

List A Short Delay Free Recall (SDFR)

Long Delay Free Recall

Lisa A Long Delay Free Recall (LDFR)

Proactive Interference

List B – List A, Trial 1

Retroactive Interference

Short Delay Free Recall (SDFR) – List A, Trial 5

Note. Table adapted from Cutting et al., 2003.
Children’s Memory Scale (CMS). The Children’s Memory Scale (Cohen, 1997) is
designed to examine learning and memory in children aged 5 to 16. The test provides a General
Memory score, which is a single composite score reflecting average memory performance across
verbal and visual domains. The test provides eight index scores: Verbal Immediate, Verbal
Delayed, Visual Immediate, Visual Delayed, Attention/Concentration, Delayed Recognition,
Learning, and General Memory. For the present study, selected subtests will be used: Stories
(component of the Verbal Immediate, Verbal Delayed, and Delayed Recognition indices) Dot
Locations (component of the Visual Immediate, Visual Delayed, and Learning indices); and
Faces (component of the Visual Immediate and Visual Delayed indices). The Stories subtest
assesses immediate and delayed recall for meaningful/semantically related information. After a
30-minute delay, a long-delay free recall, and a yes/no recognition trial are administered. The
Dot Locations consists of arranging blue chips on a grid (spatial location) over three learning
trials with immediate recall after each trial. A distractor trial (i.e., arranging red chips on a grid
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of a different orientation) is also administered which is then followed by immediate delay of the
original spatial location learned. After a 30-minute delay, a delayed recall is administered. The
Faces subtest assesses recognition of human faces. The participant is asked to remember a series
of faces and then to immediately recognize them among distractor faces. A 30-minute delayed
recall is also administered. Previous research has shown the validity and reliability of the CMS in
children with epilepsy and/or ADHD (Kibby et al., 2014; Lee et al., 2015).
Behavior Rating Inventory of Executive Function (BRIEF). The Behavior Rating
Inventory of Executive Function is a parent and teacher rating scale developed to measure
executive functioning in children aged 5 to 18 (Gioia et al., 2000a). The rating scale is comprised
of eight subscales which reflect a specific aspect of executive functioning (Inhibit, Shift,
Emotional Control, Initiate, Working Memory, Plan/Organize, Organization of Materials, and
Monitor). These subscales yield two broad composite index scores, the Behavioral Regulation
Index (BRI) and the Metacognition Index (MI), and an overall score, the Global Executive
Composite (GEC). T-scores of 65 or above on the BRIEF scales will be considered as clinically
significant in accordance with the test manual. Previous research has shown the validity and
reliability of the BRIEF in children with epilepsy and/or ADHD (Slick et al., 2006; Toplak et al.,
2008a).
Procedure
All participants underwent a comprehensive neuropsychological evaluation to assess
current level of cognitive functioning. A standard neuropsychological battery for epilepsy and
ADHD consisted of a clinical interview and measures of intellectual and achievement
functioning, language, attention and executive functions, verbal and visuospatial memory,
visuospatial/visuomotor functioning, as well as behavioral, emotional, and adaptive functioning.
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The parent and/or legal guardian of the participants completed parental report measures
including the BRIEF.
The neuropsychological testing for the pediatric epilepsy participants was part of a larger
neurological evaluation which consisted of two phases. Phase one included a pediatric
epileptologist consultation in which one of two recommendations would be implemented:
continued AED therapy or a surgical evaluation. The surgical evaluation consisted of a five-day
hospital stay in the Epilepsy Monitoring Unit (EMU) to identify the type of seizures and seizure
location via video-EEG monitoring and numerous neuroimaging scans. Following the EMU
hospitalization, the surgical case was presented in an interdisciplinary epilepsy surgery
conference in which they determined the best course of treatment. Once the interdisciplinary
team determined the best course of treatment, phase two was implemented which involved
electrode grid placement, further video-EEG monitoring, or potential surgical resection.
Results
Statistical Analysis
All analyses were performed with SPSS version 24.0. Prior to any analysis, the
assumptions of homogeneity of variance and/or normality of distribution were investigated
utilizing the Levene’s test and the Shapiro-Wilk test, respectively. Independent samples t-tests
were used to assess group differences between the total epilepsy sample and ADHD sample if
the aforementioned assumptions were not violated. However, if either of the assumptions were
violated, the non-parametric Mann-Whitney U test was utilized. Furthermore, one-way
ANOVAs were used to assess group differences between the four diagnostic groups if the
assumptions homogeneity and normality were not violated. However, if either of the assumptions
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were violated, the non-parametric Kruskal-Wallis test was utilized. Given the exploratory nature
of this study, as well as a small sample size, a p value of .05 was utilized for all analyses.
When analyzing initial relations between intelligence, memory, executive function,
and/or epilepsy factors (i.e., age of seizure onset, number of AEDs, number of failed AEDs, and
seizure frequency), Pearson correlation analyses were utilized for normally distributed variables
and Spearman Rho coefficients were utilized for non-normally distributed variables as assessed
by the Shapiro-Wilk test.
In regards to measures used, intellectual functioning was expressed in standard scores
(M=100, SD=15) whereas CMS memory scores were expressed as scaled scores (M=10, SD=3).
Z scores were used for all of the analyses of the CVLT-C. Finally, T-scores were used for all of
the analyses of the BRIEF parent ratings in order to maintain consistency with the original
analyses reported by Gioia et al. (2002). On the BRIEF, T-scores of 65 or over are indicative of
clinical-level executive impairment (i.e., scores 1.5 SD above the normative mean; Gioia et al.,
2000).
Intelligence
Age corrected standard scores from the WISC, WASI, and WAIS were used for the
overall Full Scale Intellectual Quotient score (FSIQ), as well as the four indices (i.e., Verbal
Comprehension Index (VCI), Perceptual Reasoning Index (PRI), Working Memory Index
(WMI), and Processing Speed Index (PSI)). Epilepsy and ADHD group differences in the
aforementioned indices were assessed utilizing an independent samples t-test which showed that
all indices were not significantly different, p > .05, between the two diagnostic groups. Table 6
shows the means, standard deviations (SDs), and minimum/maximum for each index and
diagnostic group. Further investigation of possible intelligence differences between the four
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diagnostic groups (i.e., intractable epilepsy, well controlled epilepsy, comorbid epilepsy/ADHD,
and ADHD) were assessed using a Kruskal-Wallis H test and showed all indices were again not
significantly different, p > .05.
Table 6
Means, SDs, and Min/Max for Intellectual Functioning Scores
Variables

ADHD

Epilepsy

Intractable
17

Controlled
42

Comorbid
15

n
30
74
FSIQ
M
95.53
92.36
89.82
95.83
85.53
SD
14.17
16.40
21.53
15.13
10.38
Min/Max
72 / 134
60 / 130
60 / 130
66 / 128
71 / 103
VCI
M
101.67
97.38
93.06
101.00
92.13
SD
16.12
16.55
18.29
17.10
9.94
Min/Max
79 / 146
63 / 142
69 / 140
63 / 142
71 / 111
PRI
M
100.33
95.34
91.76
98.81
89.67
SD
14.96
16.07
21.11
14.84
10.27
Min/Max
67 / 135
57 / 129
57 / 125
69 / 129
73 / 110
WMI
M
88.40
89.03
91.06
90.17
83.53
SD
14.73
15.13
20.51
12.78
13.88
Min/Max
65 / 141
54 / 120
62 / 120
59 / 110
54 / 120
PSI
M
91.63
86.72
86.82
89.14
79.80
SD
14.49
15.85
16.77
15.15
15.72
Min/Max
70 / 123
56 / 121
62 / 115
56 / 121
59 / 118
Note. Intractable, Controlled, and Comorbid diagnostic groups are the subsets of the Epilepsy
group. FSIQ scores are shown as standard scores (M=100, SD=15).
Memory

Delayed Memory.
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Epilepsy and ADHD Group Differences. Epilepsy and ADHD group memory
differences (CVLT-C Long Delay Free Recall (LDFR), CMS Stories Delay, CMS Dots Delay,
and CMS Faces Delay) are in Table 7 with significant differences in bold. A Mann-Whitney U
test revealed that children with epilepsy exhibited significantly lower scores on CMS Faces
Delay, U = 666, p = .002, compared to the ADHD group. Conversely, there were no significant
differences found between the two diagnostic groups on the CVLT-C LDFR (p = .554), CMS
Stories (p = .554), and CSM Dots (p = .088) between the two diagnostic groups.
Table 7
Means, SDs, and Min/Max of Delayed Memory Variables

ADHD
M
SD
Min/Max

CVLT-C
LDFR

CMS Stories
Delay

CMS Dots
Delay

CMS Faces
Delay

-0.18
1.13
-2.50 / 2.00

10.47
3.23
4 / 19

10.90
2.88
3 / 15

10.53a
2.16
7 / 16

Epilepsy
M
-0.35
9.22
9.78
8.49a
SD
1.30
3.90
3.04
3.45
Min/Max
-4.50 / 2.00
1 / 18
2 / 14
1 / 17
Note. CVLT-C scores are shown as z-scores (M=0, SD=1.5) and CMS scores are shown as
scaled scores (M=10, SD=3). Differences in bold were significant. a p < .01
Diagnostic Group Differences. Further investigation of the memory differences between
the four diagnostic groups revealed that the children with intractable epilepsy exhibited a greater
level of impairment across all CMS variables in this study. Significant differences are in bold
located in Table 8. Specifically, post-hoc Tukey tests revealed that the intractable epilepsy group
had significantly lower CMS Story Delay memory scores compared to that of the controlled
epilepsy and ADHD groups, F(3, 100) = 4.14, p = .008. Additionally, post-hoc Tukey tests
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showed that the intractable epilepsy group had significantly lower CMS Dot Delay memory
scores compared to that of the ADHD group, F(3, 100) = 2.90, p = .039. Finally, a one-way
ANOVA was conducted and showed CMS Faces Delay was significantly different, F(3, 99) =
3.22, p = .026, between diagnostic groups. Conversely, the four diagnostic groups did not differ
significantly on CVLT-C LDFR (p = .424).
Table 8
Means, SDs, and Min/Max of Delayed Memory Variables

ADHD

Intractable

Controlled

Comorbid

CVLT-C LDFR
M
-0.18
-0.41
-0.19
-0.70
SD
1.13
1.86
1.04
1.22
Min/Max
-2.50 / 2.00
-4.50 / 2.00
-3.50 / 1.50
-3.00 / 1.50
CMS Stories
M
10.47a
7.00a
10.21a
8.93
SD
3.23
4.15
3.23
4.48
Min/Max
4 / 19
1 / 15
2 / 16
2 / 18
CMS Dots
M
10.90b
8.41b
10.40
9.60
SD
2.88
3.02
2.81
3.31
Min/Max
3 / 15
3 / 13
3 / 14
2 / 13
CMS Faces
M
10.53
8.18
8.78
8.07
SD
2.16
3.47
3.48
3.53
Min/Max
7 / 16
1 / 14
1 / 17
3 / 15
Note. CVLT-C scores are shown as z-scores (M=0, SD=1.5) and CMS scores are shown as
scaled scores (M=10, SD=3). Differences in bold were significant. a p < .01; b p < .05
Memory Profiles.
Epilepsy Group. The specific memory profile for children diagnosed with epilepsy is
shown in Table 9. The results reveal overall average recognition (CVLT-C Total Recognition
Correct, CMS Story Recognition) and learning efficiency (CVLT-C Semantic Clustering).
Surprisingly, the epilepsy group also exhibited an overall average learning slope (CVLT-C Trial
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5 and CMS Dot Learning), total word recall (CVLT-C A Total), and immediate and delay recall
scores (CVLT-C Short Delay Free Recall (SDFR), CVLT-C Long Delay Free Recall (LDFR),
CMS Story Immediate, CMS Story Delay, CMS Dot Short Delay, CMS Dot Long Delay, CMS
Faces Immediate, and CMS Faces Delay).
Table 9
Means, SDs, and Min/Max of the Epilepsy Memory Profile

Mean

SD

Min/Max

Recognition
CVLT-C Recognition
-.048
1.22
-5.00 / 5.00
CMS Story Recognition
9.82
3.09
2.00 / 16.00
Learning Efficiency
CVLT-C Semantic Clustering
-.196
1.04
-3.50 / 3.00
Learning Slop
CVLT-C Trial 5
-.243
1.17
-3.50 / 1.50
CMS Dot Learning
8.93
2.76
1.00 / 14.00
Total Word Recall
CVLT-C List A Total*
46.39
11.32
20.00 / 67.00
Immediate Recall
CVLT-C SDFR
-.300
1.22
-4.00 / 2.00
CMS Stories Immediate
9.47
3.39
3.00 / 16.00
CMS Dots Short Delay
8.80
3.82
1.00 / 14.00
CMS Faces Immediate
8.85
3.38
1.00 / 18.00
Delay Recall
CVLT-C LDFR
-.345
1.30
-4.50 / 2.00
CMS Stories Delay
9.22
3.90
1.00 / 18.00
CMS Dots Long Delay
9.78
3.04
2.00 / 14.00
CMS Faces Delay
8.49
3.45
1.00 / 17.00
Note. CVLT-C scores are shown as z-scores (M=0, SD=1.5) and CMS scores are shown as
scaled scores (M=10, SD=3). *CVLT-C List A Total is shown as a T-Score (M=50, SD=10).
ADHD Group. The specific memory profile for children diagnosed with ADHD is shown
in Table 10. The results reveal overall average immediate and delay recall scores (CVLT-C
SDFR, CVLT-C LDFR, CMS Story Immediate, CMS Story Delay, CMS Dot Long Delay, CMS
Faces Immediate, and CMS Faces Delay). Surprisingly, the ADHD group exhibited no difficulty
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with initial attention (CVLT-C Trial 1 and List B) with no interference effects (CVLT-C SDFR
vs. Trial 5 and CVLT-C List B vs. Trial 1).
Table 10
Means, SDs, and Min/Max of the ADHD Memory Profile

Mean

SD

Min/Max

Immediate Recall
CVLT-C SDFR
0.00
0.91
-2.50 / 2.00
CMS Stories Immediate
10.17
2.79
5.00 / 16.00
CMS Faces Immediate
10.57
3.13
3.00 / 17.00
Delay Recall
CVLT-C LDFR
-.183
1.13
-2.50 / 2.00
CMS Stories Delay
10.47
3.12
4.00 / 19.00
CMS Dots Long Delay
10.90
2.88
3.00 / 15.00
CMS Faces Delay
10.53
2.16
7.00 / 16.00
Initial Attention
CVLT-C Trial 1
-.117
0.96
-2.00 / 2.50
CVLT-C List B
-.433
0.84
-2.00 / 1.00
Interference Effects
CVLT-C SDFR vs. Trial 5
-.317
1.12
-2.50 / 1.50
CVLT-C List B vs. Trial 1
.050
0.61
-1.50 / 1.50
Note. CVLT-C scores are shown as z-scores (M=0, SD=1.5) and CMS scores are shown as
scaled scores (M=10, SD=3).
Executive Functioning
Epilepsy and ADHD group executive functioning (BRIEF GEC) differences were
assessed utilizing an independent samples t-test. Table 11 displays the means, standard
deviations, and minimum/maximum for each diagnostic group with significant differences noted
in bold. GEC was significantly different, t(102)=-2.206, p = .030, between the two diagnostic
groups. The ADHD group had significantly higher GEC scores than the epilepsy group. Further
investigation of possible executive functioning differences between the four diagnostic groups
were assessed using a Kruskal-Wallis H test was conducted and showed GEC was not
significantly different, χ2(3) = 4.61, p = 0.203, between the four diagnostic groups.
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Table 11
Means, SDs, and Min/Max for BRIEF GEC Scores

M
SD
Min/Max

ADHD

Epilepsy

68.03a
10.20
49 / 87

62.54a
11.98
38 / 89

Intractable
62.65
15.14
46 / 89

Controlled
62.86
11.20
38 / 82

Comorbid
61.53
10.86
41 / 82

Note. Intractable, Controlled, and Comorbid diagnostic groups encompass the Epilepsy group.
BRIEF scores are shown as T-scores (M=50, SD=10). Differences in bold were significant. a p <
.05
Executive Functioning and Memory
The relationship between memory and BRIEF scales of the epilepsy group was
investigated to assess the association between aspects of memory and executive functioning. All
BRIEF subscale T-scores, as well as the index scores (i.e., Behavioral Regulation Index,
Metacognitive Index, and Global Executive Composite) were included in the analysis. As noted
earlier, Pearson correlation analyses were utilized for normally distributed variables and
Spearman Rho coefficients were utilized for non-normally distributed variables as assessed by
the Shapiro-Wilk test. Of the 44 correlations, only one was significant which unexpectedly
demonstrates a paucity of correlations between these variables as seen in Table 12.
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Table 12
Correlations Between Executive Functioning and Memory Scales
CVLT-C

CMS

CMS

CMS

Long Delay

Stories Delay

Dots Delay

Faces Delay

.115
.172
.162
-.088
.006
-.040
.240a
-.024
.192
.062
.125

.132
.022
.129
-.165
-.066
-.188
.000
-.057
.122
-.052
-.025

Inhibit
-.101
.138
Shift
-.109
-.064
Emotional Control
-.107
.119
Initiate
-.164
.029
Working Memory
-.127
-.040
Plan/Organization
-.184
.081
Organization of Materials
-.049
.192
Monitor
-.066
.074
BRI
-.111
.094
MI
-.081
.081
GEC
-.125
.096
a
Note. Correlations in bold were significant. p < 0.05

To investigate further the possibility of a relationship between executive functioning and
memory scores among the epilepsy group, comparative analyses were also conducted. An
independent samples t-test was performed to compare the highest and lowest thirds of the sample
based on their BREF GEC scores with their delayed memory scores from the CVLT-C and CMS.
The results revealed there no significant difference in memory scores between those with lower
and higher clinical impairments as measured by the GEC on the BRIEF.
Epilepsy Factors and Intelligence
The relationship between seizure variables and scores on IQ assessments were calculated
to investigate the association between epilepsy factors and intellectual functioning. Table 13
displays the correlations between the seizure variables and IQ indices with significant
correlations in bold. The seizure variables included in the analyses are as follows: Age of seizure
onset, time since seizure onset, number of current AED medications, and number of failed AED
medications. Due to prior analyses revealing that there were no significant differences between
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the epilepsy diagnostic groups and intelligence indices (i.e., FSIQ, VCI, PRI, WMI, and PSI), the
total epilepsy group was utilized to investigate the relationship between epilepsy factors and
intelligence. The results indicated earlier age of seizure onset was associated with lower scores
FSIQ (p=.008) and VCI scores (p = .005). Additionally, higher number of current AED
medications was associated with lower FSIQ (p = .004) and PRI scores (p = .007). Finally, a
higher number of failed AED medications was associated with lower PRI scores (p = .009).
Table 13
Correlations for Epilepsy Variables and Intellectual Functioning Scores
Age at Seizure
Time Since
Onset
Seizure Onset
a
Verbal Comprehension Index
.313
-.256
Perceptual Reasoning Index
.232
-.227
Working Memory Index
.205
-.276
Processing Speed Index
.106
-.284
a
Full Scale IQ
.329
-.291
a
Note. Correlations in bold were significant. p < 0.01
Variables

Number of
AEDs
-.201
-.286
-.258
-.316a
-.334a

Number of
Failed AEDs
-.253
-.305a
-.061
-.147
-.260

Epilepsy Factors and Memory
The relationship between seizure variables and scores on memory assessments was
investigated to assess the association between aspects of epilepsy and memory. Due to prior
analyses revealing that there were no significant differences between the epilepsy diagnostic
groups and specific memory variables (i.e., CVLT-C LDFR, CMS Dots Delay, and CMS Faces
Delay), the total epilepsy group was utilized to investigate the relationship between epilepsy
factors and these aforementioned memory variables. However, previous analyses revealed
significantly different memory scores of the CMS Stories Delay among the intractable and
controlled epilepsy groups. Therefore, the relationship between epilepsy factors and CMS Stories
Delay was further analyzed with respect to each epilepsy diagnostic group.
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Total Epilepsy Group. The earlier age of seizure onset (p = .049) and longer duration
since seizure onset (p = .015) were associated with lower scores on CMS Faces Delay, as shown
in Table 14. Additionally, higher number of current AED medications was associated with lower
scores on all the CMS Delay variables (Stories, p = .011; Dots, p = .026; Faces, p = .008).
Finally, a higher number of failed AED medications was associated with lower CMS Stories (p =
.034) and Dots (p = .028) Delay scores.
Table 14
Correlations for Epilepsy Variables and Memory Scores
Age at Seizure
Time Since
Onset
Seizure Onset
CVLT-C LDFR
.212
-.108
CMS Stories Delay
.006
-.045
CMS Dots Delay
-.052
-.093
a
CMS Faces Delay
.236
-.289a
Note. Correlations in bold were significant. a p < 0.05; b p < 0.01
Variables

Number of
AEDs
-.185
-.268a
-.236a
-.281b

Number of
Failed AEDs
-.064
-.249a
-.257a
-.074

Diagnostic Group Differences. Likely due to the small sample size, there were no
significant correlations between the seizure variables and CMS Stories Delay scores for any
given epilepsy diagnostic group, as shown in Table 15.
Table 15
Correlations for Epilepsy Variables and CMS Stories Delay Scores
Variables

Age at Seizure

Time Since

Number of

Number of

Onset

Seizure Onset

AEDs

Failed AEDs

.094
-.093
-.429

.264
.090
-.343

Intractable Group
.213
-.327
Controlled Group
-.010
.043
Comorbid Group
-.244
.176
Note. No significant correlations were found at the 0.05 level.
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Epilepsy Factors and Executive Functioning
The relationship between seizure variables and scores on the BRIEF was investigated to
assess the association between aspects of epilepsy and executive functioning. Age and gender
corrected T-scores were used for the three composite indices (Behavioral Regulation Index
(BRI), Metacognition Index (MI), and an overall score, the Global Executive Composite (GEC)),
(FSIQ), as well as eight subscales which reflect a specific aspect of executive functioning
(Inhibit, Shift, Emotional Control, Initiate, Working Memory, Plan/Organize, Organization of
Materials, and Monitor). The means for the BRIEF indices and subscales are shown in Table 16.
The Working Memory scale was the only scale that reached clinical significance (T<65).
However, many other scores fell within the sub-clinical range, which suggests these may be
areas of concern in terms of executive dysfunction (T = 60-64).
Table 16
Means for BRIEF Scores of the Epilepsy Groups
Variables

Epilepsy

Intractable
Inhibit
57.99
58.29
Shift
60.50
63.94
Emotional Control
55.28
57.12
Initiate
61.42
62.18
Working Memory
67.18
68.65
Planning/Organizing
61.84
59.24
Organization of Materials
54.85
52.94
Monitor
61.41
58.82
BRI
58.76
60.65
MI
63.82
62.12
GEC
62.54
62.65
Note. BRIEF scores are shown as T-Scores (M=50, SD=10).

Controlled
56.98
60.07
55.83
60.50
66.57
62.88
56.74
61.93
58.59
64.76
62.86

Comorbid
60.47
57.80
51.67
63.13
67.20
61.87
51.73
62.87
57.07
63.13
61.53

One-way ANOVAs were conducted and showed that all the BRIEF subscales and indices
were not significantly different, p > .05, between diagnostic groups. Therefore, the total epilepsy
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group was utilized to investigate the relationship between epilepsy factors and executive
functioning. Of the 44 correlations found in Table 17, surprisingly only two epilepsy and
executive functioning variables were correlated. The results indicated earlier age of seizure onset
was associated with higher scores in Planning/Organizing (r = -.27, p = .025) and Monitoring (r
= -.26, p = .029).
Table 17
Correlations for Epilepsy Variables and BRIEF Scores
Age at Seizure
Time Since
Onset
Seizure Onset
Inhibit
-.070
.043
Shift
-.088
-.085
Emotional Control
-.139
.013
Initiate
-.148
.073
Working Memory
-.168
.081
a
Planning/Organizing
-.265
.136
Organization of Materials
-.119
-.014
a
Monitor
-.259
.081
BRI
-.117
.003
MI
-.199
.055
GEC
-.196
.062
a
Note. Correlations in bold were significant. p < 0.05
Variables

Number of
AEDs
-.172
-.073
-.119
.136
.092
.072
-.110
-.043
-.156
.005
-.060

Number of
Failed AEDs
.039
-.029
-.069
-.002
-.012
-.199
-.047
-.068
-.028
-.151
-.110

Predictors of Memory Functioning
Epilepsy Group. A standard multiple regression analysis was utilized to assess the
ability of the global intelligence (FSIQ), global executive functioning (BRIEF GEC), and age of
seizure onset to predict memory functioning in the epilepsy group as measured by the CVLT-C
LDFR, CMS Stories Delay, CMS Dots Delay, and CMS Faces Delay. The results indicated that
FSIQ, BRIEF GEC, and age of seizure onset provided a statistically significant prediction of
every delayed memory score. The FSIQ, BRIEF GEC, and age of seizure accounted for the
greatest variance (21%) in the CMS Stories Delay (F(3, 67) = 5.972, p = .001, R2 = .211, adj. R2 =
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.176), followed by 20% of the variance in the CVLT-C LDFR (F(3, 67) = 5.593, p = .002, R2 =
.200, adj. R2 = .164), 15% of the variance in CMS Faces Delay (F(3, 66) = 3.918, p = .012, R2 =
.151, adj. R2 = .113), and 13% of the variance in the CMS Dots Delay (F(3, 67) = 3.391, p =
.023, R2 = .132, adj. R2 = .093). Of these predictors of memory function (i.e., FSIQ, BRIEF GEC,
and age of seizure onset), FSIQ contributed unique variance of all the memory predictions.
Regression coefficients and standard errors can be found in Table 18.
Table 18
Summary of Multiple Regression Analysis of Memory Scores Among the Epilepsy Group
B

SEB

β

CVLT-C LDFR
Intercept
-2.921
1.128
FSIQ
.033
.009
.414a
BRIEF GEC
-.009
.012
-.081
Age Seizure Onset
.016
.038
.051
CMS Stories Delay
Intercept
-2.561
3.391
FSIQ
.114
.028
.476b
BRIEF GEC
.034
.036
.102
Age Seizure Onset
-.137
.115
-.141
CMS Dots Delay
Intercept
2.557
2.743
FSIQ
.067
.022
.364a
BRIEF GEC
.027
.029
.108
Age Seizure Onset
-.119
.093
-.158
CMS Faces Delay
Intercept
1.155
3.125
FSIQ
.069
.026
.329a
BRIEF GEC
.005
.034
.016
Age Seizure Onset
.107
.106
.124
a
b
Note. Significant predictors are in bold. p < .01, p < .001; B = unstandardized regression
coefficient; SEB = Standard error of the coefficient; β = standardized coefficient.
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ADHD Group. A standard multiple regression analysis was utilized to assess the ability
of the global intelligence (FSIQ) and global executive functioning (BRIEF GEC) to predict
memory functioning in the ADHD participants as measured by the CVLT-C LDFR, CMS Stories
Delay, CMS Dots Delay, and CMS Faces Delay. The results indicated that FSIQ and BRIEF
GEC provided a statistically significant prediction of all the memory scores except CMS Faces
Delay. The FSIQ and BRIEF GEC predict the greatest variance (30%) in the CMS Dots Delay
(F(2, 27) = 5.824, p = .008, R2 = .301, adj. R2 = .250), followed by 28% of the variance in the
CVLT-C LDFR (F(2, 27) = 5.318, p = .011, R2 = .283, adj. R2 = .229), and 23% of the variance in
the CMS Stories Delay (F(2, 27) = 4.055, p = .029, R2 = .231, adj. R2 = .174). Of these predictors
of memory function (i.e., FSIQ and BRIEF GEC), FSIQ contributed unique variance within the
CVLT-C LDFR and CMS Dots Delay memory scores. Regression coefficients and standard
errors can be found in Table 19.

58
Table 19
Summary of Multiple Regression Analysis of Memory Scores Among the ADHD Group
B

SEB

β

CVLT-C LDFR
Intercept
-1.433
1.615
FSIQ
.039
.013
.487a
BRIEF GEC
-.036
.018
-.327
CMS Stories Delay
Intercept
-3.032
4.773
FSIQ
.075
.039
.327
BRIEF GEC
.094
.055
.295
CMS Dots Delay
Intercept
-1.289
4.052
FSIQ
.105
.033
.516a
BRIEF GEC
.032
.046
.686
CMS Faces Delay
Intercept
9.903
3.335
FSIQ
-.044
.027
-.289
BRIEF GEC
.071
.038
.336
a
Note. Significant predictors are in bold. p < .01; B = unstandardized regression coefficient; SEB
= Standard error of the coefficient; β = standardized coefficient.
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Discussion
Review of Results
The purpose of this study was to examine the impact of executive dysfunction on
memory in a pediatric epilepsy and ADHD sample. My data shows one way how the
predictability of memory performance based on EF may be the result of the dissociation between
parent-report and performance-based EF measures. Previous studies have demonstrated that
performance-based and parent-report measures of EF are not associated with one another
(MacAllister et al., 2012a; Ten Eycke & Dewey, 2016). Furthermore, different constructs of EF
are found to be measured by parent-report versus performance-based assessments (Ten Eycke &
Dewey, 2016). Therefore, the investigation of the predictive nature of executive dysfunction for
specific cognitive performance (e.g., memory) is of importance. Overall, although we found that
intellectual functioning, EF, and age of seizure onset were significant predictors for every
delayed memory score in children with epilepsy, it was the intellectual functioning variable that
controlled this relationship. Similarly, intellectual and EF were significant predictors for the
majority of the delayed memory scores in children with ADHD, however, similar to the findings
with epilepsy, intellectual functioning was the only unique predictor. These findings are not
surprising as prior research has shown that intellectual functioning is strongly related to both EF
and memory (Diamond, 2013; Joordens, Walsh, Mantonakis, 2013). Thus, EF was not a unique
predictor of delayed memory performance within the epilepsy and ADHD groups, disproving
hypothesis 5 and 6. Similarly, reduced memory performance was not related to greater executive
dysfunction, disproving hypothesis 4. These findings are inconsistent with Sepeta et al. (2017)
who found that Planning/Organization and Working Memory in everyday settings as reported by
parents significantly predicted verbal memory in pediatric focal epilepsy. These contradictions in
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the predictive nature of executive dysfunction for memory indicates that further research is
needed to delineate the relationship between these cognitive domains.
In regards to hypothesis 1, some anticipated findings were discovered such that the
children with epilepsy demonstrated lower memory performance compared to children with
ADHD. Specifically, the overall epilepsy group produced significantly lower scores on
contextual/visual memory whereas the intractable epilepsy group obtained significantly lower
scores on visual-spatial memory compared to that of the children with ADHD. Additionally, the
intractable epilepsy group demonstrated significantly lower verbal story memory than the ADHD
and the controlled epilepsy groups. As stated previously, these findings were not surprising. In
their comprehensive review, Menlove & Reilly (2015) noted 78% of previous studies reported
lower memory performance for children with epilepsy when compared to control groups and
normative scores. However, in the present study, the children with comorbid epilepsy/ADHD did
not demonstrate significantly reduced memory performance compared to the other groups. These
findings are inconsistent with the present hypothesis 2 and with Lee et al. (2016) who found that
comorbid epilepsy/ADHD exhibited the greatest deficits on all the attention and memory
measures as compared to the epilepsy and ADHD groups individually. As such, it should be
noted that the comorbid group obtained the lowest scores on all of the intelligence indices as well
as half of the memory scales (i.e., list learning and contextual visual memory). Moreover, it must
be considered that true differences may not have been detected due to small groups sizes
(comorbid group, n=15). Future research should attempt to replicate these results in a larger
sample of children with epilepsy and/or ADHD, as our small sample size limited our ability to
detect significant group differences.

61
Despite obtaining significantly lower memory scores than the children with ADHD, the
epilepsy groups still achieved average memory scores as well as an average learning slope and
total word recall. These findings did not support hypothesis 3 and also were inconsistent with
Nolan et al. (2004) and Lopes et al. (2014) who found that children with frontal, temporal, or
childhood absence epilepsy obtained borderline scores on measures of visual and verbal
memory. However, research in this area historically has been inconsistent (Borden, Burns, &
O’Leary, 2007; Williams et al., 2001). Some factors that may contribute to the lack of consistent
findings in memory abilities in children with epilepsy may result from varying
etiology/pathology of the epileptic seizures, the diffuse cognitive effects of seizures (Williams et
al., 2001), and/or the plasticity of brain structures in children (Baron, 2004). Borden et al. (2007)
found that children with epilepsy did not differ significantly on the majority of the CMS subtests
when intellectual functioning was matched. It is difficult to determine whether children with
epilepsy demonstrate memory specific deficits or global cognitive weaknesses. Therefore,
intellectual functioning appears to have a mediating and predictive effect on children’s memory
and is important to control in future studies.
In regards to hypothesis 3b, the ADHD group predictably demonstrated average overall
memory. However, the children with ADHD unexpectedly demonstrated average initial
attention. It should be noted only 27% (n = 8) of the children in the ADHD were currently taking
medication (e.g., Vyvanse, Concerta, Focalin) for attention difficulties. Additionally, this group
exhibited no difficulty with proactive and retroactive interference on the 15-item word list,
disputing this hypothesis. The overall memory findings are consistent with Lee et al. (2016) such
that the children with ADHD have intact memory and have successfully encoded the learned
material. Contrary to this hypothesis, Lee et al. (2016) also found that the children with ADHD
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demonstrated deficits in focused attention and encoding when material was presented once and
needed to be coded verbatim/in sequential order. It should be considered that the inconsistencies
between the studies could be due to smaller groups sizes (ADHD group, n=30). As such, it
should be noted that the ADHD group obtained the lowest scores on the distractor list recall and
proactive interference variable. Future research should attempt to verify these results in a larger
sample of children with ADHD.
Regarding the exploratory analyses between epilepsy severity factors and specific
cognitive domains, longer epilepsy duration and younger age of seizure onset were associated
with reduced contextual visual memory. Additionally, earlier age of seizure onset was
significantly associated with reduced overall intelligence, verbal comprehension, and executive
functioning such as planning/organizing and self-monitoring. These findings were expected, as
the relationship between seizure duration and/or age of seizure onset with aforementioned
deficits is well documented (Fuentes & Smith, 2015; Lopes et al., 2014; Love et al., 2016;
Menlove & Reilly, 2015; Nolan et al., 2004). Participants currently taking a greater number of
AEDs demonstrated significantly reduced processing speed, overall intelligence, as well as
verbal and visual delayed memory. These findings are consistent with prior research which has
shown that polypharmacy is related to lower cognitive skills in pediatric epilepsy (Kellogg &
Meador, 2017; Ortinski & Meador, 2004). Regarding number of failed AEDs, participants who
had experienced a greater number of failed AEDs scored lower on perceptual reasoning, story
memory, and visual-spatial memory. These findings were expected, as the relationship between
intractable epilepsy and number of failed AEDs with aforementioned deficits is well documented
(Fuentes & Smith, 2015; Lopes et al., 2014; Love et al., 2016; Menlove & Reilly, 2015).
In contrast to the findings above, time since seizure onset was not associated with any
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intellectual or executive functioning scales. Additionally, there was no significant relationship
regarding the number of current AEDs and executive functioning. These findings may indicate
that epilepsy severity cannot be explained by a single factor. Therefore, a more comprehensive
approach must be considered when understanding the relationship between epilepsy severity and
specific cognitive impairments such as intelligence, memory, and EF.
Strengths, Limitations, and Additional Future Directions
The current study presents ongoing support that greater impairments in intellectual
functioning and EF result in poorer memory in children with epilepsy and ADHD, with
intellectual functioning being the critical predicting factor. Only two studies have been
conducted which examine this relationship in pediatric epilepsy patients (Rzezak et al., 2012;
Sepeta et al., 2017). However, these studies did not include the possible contributions of other
conditions, such as the highly comorbid ADHD diagnosis in childhood epilepsy. Therefore, the
present study provided a unique contribution to the literature by being the first study to
investigate the effects of executive dysfunction on memory in pediatric epilepsy and ADHD
population.
This study was not without limitations. First, the current study represents a small sample
of 104 children with epilepsy and/or ADHD. Accordingly, this may have limited the ability to
detect true significant relationships and differences between parent-reported EF and memory.
Future studies should also aim to include the inclusion of healthy controls to assist further in
delineating this relationship. Second, controlling for intellectual functioning should be
considered in future research as intellectual functioning is strongly related to both EF and verbal
memory. Controlling for intellectual functioning would allow researchers to conclude whether
EF predicts verbal memory performance above and beyond FSIQ. Finally, previous studies
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demonstrated that performance-based and parent-report measures are not associated with one
another (MacAllister et al., 2012a; Ten Eycke & Dewey, 2016). Therefore, future studies of EF
and memory in children with epilepsy and/or ADHD should consider including both
performance-based and parent-report measures of EF.
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Glossary
a

Atonic seizure – generalized seizure characterized by complete loss of muscle
tone; a drop attack.

a

Atypical seizure – an absence seizure is “atypical” because of slow onset or termination or
significant changes in tone supported by atypical, slow, generalized spike and wave on
the EEG.

a

Automatism – involuntary, nondirected movements during impaired awareness focal seizure
and atypical absence seizures usually involving the hands (e.g., picking motions), mouth
(e.g., lip smacking), or voice (e.g., repetitive vocalization).

a

Autonomic seizure – autonomic signs are often a component of focal seizures; often an aura in
impaired awareness seizures.

b

Awareness – focal seizure classification in which the individual is aware of him/herself and
environment during the seizure, even if immobile.

c

Central executive – responsible for the coordination and monitoring of the slave systems (i.e.
visuospatial sketchpad and phonological loop) in Baddeley’s working memory model.

a

Clonic seizure – seizures characterized by either focal or generalized rhythmic clonic jerks that
varying frequency and amplitude.

b

Cognitive seizure – seizures classified by impaired language or other cognitive domains or
positive features such as déjà vu, hallucinations, illusions, or perceptual distortions.
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d

Declarative memory – Conscious, intentional remembering of events, facts, and personal
experiences that depends on conceptually driven, top-down processing in which a person
recognizes the data to store it.

a

Electroencephalography (EEG) – amplified recording of electrical signals produced by
cerebral neuronal activity.

b

Emotional seizure – involves anxiety, fear, joy, other emotions, or appearance of affect
without subjective emotions.

e

Epileptic spasms - sudden flexion, extension or mixed flexion-extension of proximal and
truncal muscles, lasting 1-2 seconds i.e. longer than a myoclonic jerk (which lasts
milliseconds) but not as long as a tonic seizure (which lasts > 2 seconds). Spasms
typically occur in a series, usually on wakening. Subtle forms may occur with only chin
movement, grimacing, or head nodding. Spasms may be bilaterally symmetric,
asymmetric, or unilateral.

a

Epilepsy – a chronic neurological condition characterized by two unprovoked seizures.

a

Epileptic syndrome – a cluster of signs and symptoms customarily occurring together
including such things as seizure type, etiology, anatomy, precipitating factors, onset age,
severity, chronicity, and sometimes prognosis.
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f

Episodic buffer – a component of Baddeley’s working memory model; responsible for
combining the visual and auditory information in order to link this information to the
episodic memory system.

g

Executive functioning - domain of cognitive functioning which encompasses the four
components of volition, planning and decision making, purposeful action, and effective
performance.

a

Eyelid myoclonia seizure - forced upward jerking of the eyelids during an absence seizure.

h

Focal cortical dysplasia - malformations in cortical lamination, neuronal differentiation, or
neuronal maturation.

i

Focal seizure – seizure occurring within networks limited to one hemisphere and either
discretely localized or more widely distributed.

j

Focal to bilateral tonic-clonic seizure – seizures that start in a limited area on one side of the
brain and spread to involve both sides of the brain.

a

Generalized seizure – an epileptic seizure that involves most or all of the brain bilaterally.

k

Hyperkinetic seizure - seizures characterized by intense motor activity involving the
extremities and trunk.

a

Idiopathic – etiology unknown; idiopathic epilepsy syndromes are most often due to inherited
(genetic) factors.
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a

Myoclonic seizure – generalized seizures consisting of brief, violent muscle contractions that
are usually bilateral without any apparent impairment of consciousness.

d

Nondeclarative memory – Unconscious and nonintentional memory of learned skills,
conditioned reactions, and events.

c

Phonological loop – a component of Baddeley’s working memory model; stores and rehearses
speech-based information and is necessary for the acquisition of both native and second
language vocabulary; consists of two subsystems – phonological store and articulatory
control process.

l

Sensory seizure – a seizure that causes a change in any one of the senses. People with sensory
seizures may smell or taste things that aren’t there; hear clicking, ringing, or a person’s
voice when there is no actual sound; or feel a sensation of “pins and needles” or
numbness.

a

Tonic seizure – a seizure characterized by sustained muscular contraction.

a

Tonic-clonic seizure – a generalized seizure most known for bilateral rhythmic convulsions of
the limbs and face; evolves across three stages: tonic phase, tonic-clonic phase, and
postictal phase.
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a

Typical absence seizure – a “typical” absence attack is a generalized seizure most common in
children; consists of a lapse of consciousness with a blank stare lasting only a few
seconds; often accompanied with rapid eye blinking.

a

Unclassified seizure – a seizure may be unclassified due to inadequate information or inability
to place the seizure type in other categories.

c

Visuospatial sketchpad – a component of Baddeley’s working memory model; manipulates
visual images in working memory.

c

Working memory - a brain system that provides temporary storage and manipulation of the
information necessary for such complex cognitive tasks as language comprehension,
learning, and reasoning.
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